產品詳情
所在位置: 首頁> 產品目錄> 細胞庫>
  • 產品名稱:正常肝細胞多少錢?

  • 產品型號:******************/xibaopeiyang/
  • 產品廠商:其它品牌
  • 產品文檔:
你添加了1件商品 查看購物車
簡單介紹:
正常肝細胞多少錢? ******************/xibaopeiyang/ 上海佰曄生物科技有限公司提供ATCC細胞庫、ABMgood細胞庫、SXBIO細胞庫、CBR細胞庫、CellBank Australia細胞庫、DSMZ細胞庫、ECACC細胞庫、JCRBC細胞庫、KCLB細胞庫、Paratechs細胞庫、RIKEN細胞庫、ScienCell細胞庫的所有原代、傳代(第三代)產品。正常肝細胞多少錢?http://******************/xibaopeiyang/ SXBIO細胞庫 來源好 無黑點 復蘇運輸穩定 易傳代 正常肝細胞多少錢?
詳情介紹:

正常肝細胞多少錢? 上海佰曄生物科技有限公司提供ATCC細胞庫、ABMgood細胞庫、SXBIO細胞庫、CBR細胞庫、CellBank Australia細胞庫、DSMZ細胞庫、ECACC細胞庫、JCRBC細胞庫、KCLB細胞庫、Paratechs細胞庫、RIKEN細胞庫、ScienCell細胞庫的所有原代、傳代(第三代)產品。正常肝細胞多少錢?http://


SXBIO細胞庫 來源好 無黑點 復蘇運輸穩定 易傳代 正常肝細胞多少錢?



產品目錄 >>> SXBIO細胞庫 >>> 人正常組織來源細胞




簡單介紹


人肝癌血管內皮細胞 TEC 貨號:TCHU82


人肝癌血管內皮細胞 TEC 貨號:TCHU82  的詳細介紹


名稱:人肝癌血管內皮細胞


英文縮寫(TEC)


貨號:TCHU82



正常肝細胞怎么培養?



產品目錄 >>> ATCC原代細胞庫 >>> ATCC原代細胞株


簡單介紹


atcc HTB-31(C-33 A細胞)


ATCC HTB-31(C-33 A細胞)  的詳細介紹


atcc HTB-31(C-33 A細胞)標準細胞株基本信息


出品公司: ATCC


細胞名稱: ATCC HTB-31(C-33 A細胞), C-33 A, 人子*宮頸癌細胞


存儲人: N Auersperg


種屬來源: 人


組織來源: 子*宮


疾病特征: 宮頸癌


細胞形態: 上皮細胞樣


生長特性: 貼壁生長


培養基: MEM培養基(MEM,gibco,貨號41500034),90%;FBS,10%。


產品目錄號: HTB-31


生長條件: 氣相:空氣,95%;二氧化碳,5%; 溫度:37 ℃,


傳代方法: 1:2至1:6,每周2次。


凍存條件: 90% 完全培養基+10% DMSO,液氮儲存


支原體檢測: 陰性


**等級: 1


STR:


Amelogenin: X


CSF1PO: 12


D13S317: 13


D16S539: 13,14


D5S818: 11,12


D7S820: 10


THO1: 7,8


TPOX: 9


vWA: 18,20


同工酶:


AK-1, 1


ES-D, 1


G6PD, B


GLO-I, 2


Me-2, 2


PGM1, 1


PGM3, 1


參考文獻:


J. Natl. Cancer Inst. 32: 135-148, 1964.


Yee C, et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119: 361-366, 1985. PubMed: 2990217


Scheffner M, et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88: 5523-5527, 1991. PubMed: 1648218


Hendricks DT, et al. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res. 57: 2112-2115, 1997. PubMed: 9187105


Kovelman R, et al. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70: 7549-7560, 1996. PubMed: 8892874


C-33 A細胞人子*宮頸癌細胞特點和簡介


C-33 A 細胞株是N. Auersperg從宮頸癌切片中建立的一系列細胞株(參見ATCC CRL-1594和ATCC CRL-1595)中的一株。 細胞一開始就表現出亞二倍體核型及上皮細胞形態。 連續傳代可以觀察到核型不穩定。 存在成視網膜細胞瘤蛋白(pRB),但大小不正常。 P53表達上調,且有一個273位密碼子的點突變導致Arg -> Cys的替換。 人**瘤病毒DNA及RNA陰性。 在本庫通過支原體檢測。 在本庫通過STR檢測。


C-33 A細胞人子宮頸癌細胞接受后處理


1)  收到細胞后,請檢查是否漏液 ,如果漏液,請拍照片發給我們。


2)  請先在顯微鏡下確認細胞生長 狀態,去掉封口膜并將T25瓶置于37℃培養約2-3h。


3)  棄去T25瓶中的培養基,添加 6ml本公司附帶的完全培養基。


4)  如果細胞密度達80%-90%請及 時進行細胞傳代,傳代培養用6ml本公司附帶的完全培養基。


5)  接到細胞次日,請檢查細胞是 否污染,若發現污染或疑似污染,請及時與我們取得聯系。


C-33 A細胞人子宮頸癌細胞培養操作


1)復蘇細胞:將含有 1mL 細胞懸液的凍存管在 37℃水浴中迅速搖晃解凍,加 入 4mL 培養基混合均 勻。在 1000RPM 條件下離心 4 分鐘,棄去上清液,補 加 1-2mL 培養基后吹勻。然后將所有細胞懸液加入培養瓶中培 養過夜(或將 細胞懸液加入 10cm 皿中,加入約 8ml 培養基,培養過夜)。**天換液并 檢查細胞密度。


2)細胞傳代:如果細胞密度達 80%-90%,即可進行傳代培養。


1. 棄去培養上清,用不含鈣、鎂離子的 PBS 潤洗細胞 1-2 次。


2. 加 1ml 消化液(0.25%Trypsin-0.53mM EDTA)于培養瓶中,置于 37℃培 養箱中消化 1-2 分鐘,然后在顯微鏡下觀察細胞消化情況,若細胞大部分 變圓并脫落,迅速拿回操作臺,輕敲幾下培養 瓶后加少量培養基終止消 化。


3. 按 6-8ml/瓶補加培養基,輕輕打勻后吸出,在 1000RPM 條件下離心 4 分 鐘,棄去上清液,補加 1-2mL 培養液后吹勻。


4. 將細胞懸液按 1:2 比例分到新的含 8ml 培養基的新皿中或者瓶中。


3)細胞凍存:待細胞生長狀態良好時,可進行細胞凍存。下面 T25 瓶為類;


1. 細胞凍存時,棄去培養基后,PBS 清洗一遍后加入 1ml 胰酶,細胞變圓 脫 落后,加入 1ml 含血清的培養基終止消化,可使用血球計數板計數。


2. 4 min 1000rpm 離心去掉上清。加 1ml 血清重懸細胞,根據細胞數量加 入血 清和 DMSO,輕輕混勻,DMSO 終濃度為 10%,細胞密度不低于1x106/ml,每支凍存管凍存 1ml 細胞懸液,注意凍 存管做好標識。


3. 將凍存管置于程序降溫盒中,放入-80 度冰箱,2 個小時以后轉入液氮灌儲存。記錄凍存管位置以便下次拿取。


C-33 A細胞人子宮頸癌細胞培養注意事項


1. 收到細胞后首先觀察細胞瓶是否完好,培養液是否有漏液、渾濁等現象,若有上述現 象發生請及 時和我們聯系。


2. 仔細閱讀細胞說明書,了解細胞相關信息,如細胞形態、所用培養基、血清比例、所 需細胞因子 等,確保細胞培養條件一致。若由于培養條件不一致而導致細胞出現問 題,責任由客戶自行承擔。


3.   用 75%酒精擦拭細胞瓶表面,顯微鏡下觀察細胞狀態。因運輸問題貼壁細胞會有少量 從瓶 壁脫落,將細胞置于培養箱內靜置培養 4~6 小時,再取出觀察。此時多數細胞均 會貼壁,若細胞仍不能貼壁請用臺盼藍 染色測定細胞活力,如果證實細胞活力正常, 請將細胞離心后用新鮮培養基再次貼壁培養;如果染色結果顯示細胞無活 力,請拍下 照片及時和我們聯系,信息確認后我們為您再免費寄送一次。


4.   靜置細胞貼壁后,請將細胞瓶內的培養基倒出,留 6~8mL 維持細胞正常培養,待細 胞匯 合度  80%左右時正常傳代。


5. 請客戶用相同條件的培養基用于細胞培養。培養瓶內多余的培養基可收集備用,細胞 傳代時可以 一定比例和客戶自備的培養基混合,使細胞逐漸適應培養條件。


6.   建議客戶收到細胞后前 3 天各拍幾張細胞照片,記錄細胞狀態,便于和 Procell 技術 部 溝通交流。由于運輸的原因,個別敏感細胞會出現不穩定的情況,請及時和我們聯 系,告知細胞的具體情況,以便我們 的技術人員跟蹤回訪直至問題解決。


7. 該細胞僅供科研使用。


ATCC HTB-31(C-33 A細胞)標準細胞株說明書pdf版和相關資料下載


ATCC HTB-31(C-33 A細胞)標準細胞株應用舉例




正常肝細胞好不好養?



產品目錄 >>> ScienCell原代細胞庫 >>> 原代細胞株


簡單介紹


大鼠巨噬細胞 RSMa


大鼠巨噬細胞 RSMa  的詳細介紹


Macrophages are cells differentiated from circulating bone marrow-derived monocytes. The main function of macrophages is to remove cellular debris and destroy invading pathogens. Rat Splenic Macrophages (RSMa) reside in the spleen and play a critical role in maintaining blood homeostasis [1]. There are three distinct populations of splenic macrophages including: red pulp macrophages, marginal zone macrophages, and marginal zone metallophillic macrophages [1, 2]. RSMa perform iron processing functions and aid in the capture of microbes and viruses in the circulatory system [1, 2]. Recent studies have shown that splenic macrophages contribute to stroke pathology and autoimmune diseases [3, 4]. RSMa are an excellent model for studying macrophage functions under normal physiological and pathological conditions.


RSMa from ScienCell Research Laboratories are isolated from ***** CD® IGS rat spleen. RSMa are cryopreserved after purification and delivered frozen. Each vial contains > 1 x 106 cells in 1 ml volume. RSMa are characterized by immunofluorescence with antibody to F4/80. RSMa are negative for mycoplasma, bacteria, yeast, and fungi. RSMa are guaranteed to further culture in the conditions provided by ScienCell Research Laboratories; however, RSMa are not recommended for expanding or long-term cultures since the cells do not proliferate in regular culture.


貨號 R5550


產地 北美


縮寫 RSMa


規格 5 x 10^5 /1ml


用途 科研


儲存 液氮


運輸 干冰




正常肝細胞用什么培養基?



產品目錄 >>> ABMgood細胞庫 >>> 永生化原代細胞(Immortalized Primary Cells)


簡單介紹


Immortalized-Human-Benign-Prostate-Epithelial-Cell---SV40


Immortalized-Human-Benign-Prostate-Epithelial-Cell---SV40  的詳細介紹


Print Version


BioSafety Level II


Organism Homo sapiens


Source Organ Prostate


Donor Age 68


Donor Gender Male


Growth Properties Adherent


Morphology Polygonal


Passage Number 10


Population Doubling 24-28 hours


Recommended Seeding Density Thaw entire contents into an appropriate T25 flask as specified in the Propagation instructions.


Applications For Research Use Only


Immortalization Method Serial passaging and infection with ZipneoSV virus carrying SV40 T antigen gene


Cell Type Characterization


Procedure Overview


Image


Propagation Use of PriCoat? T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. Grow cells in ECM-coated culture vessels with the following conditions. The base medium for this cell line is Prigrow II medium available in ABM, Cat. No. TM002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (TM999) to a final concentration of 10% and Penicillin/Streptomycin(G255). Atmosphere: air, 95%; Carbon dioxide (CO2), 5%. Temperature: 37.0°C


Quality Control Real Time PCR was used to quantify SV40 gene expression in immortalized cell line.


Reference Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P.


(1994). Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim. 1995 Jan;31(1):14-24.


Disclaimer 1. The CoA for this product (provided upon request) verifies the cell-type specific gene expression via RT-PCR only. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.


2. We strongly recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).


3. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.


4. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.





正常肝細胞是貼壁細胞還是懸浮細胞?



產品目錄 >>> Paratechs細胞庫 >>> VE-BEVS昆蟲細胞系


VE-CL-03細胞系


VE-CL-03細胞系


點擊看大圖


如果您對該產品感興趣的話,可以跟我洽談;給我留言


產品名稱: VE-CL-03細胞系


產品型號: 10030


產品展商: Paratechs


美元($)價格: 0.00 元


歐元(€)價格: 0.00 元


人民幣(¥)價格: 0.00 元


產品文檔: 無相關文檔


發布時間:2018-06-20


簡單介紹


VE-CL-03細胞系 paratechs VE-CL-03 cells Product number: 10030 Unit: 107cells/ml Price: $800 VE-CL-03 cell line Sf9-derived cell line for general enhancement of most recombinant proteins. VE-CL-03細胞系 paratechs


VE-CL-03細胞系  的詳細介紹


VE-CL-03細胞系 paratechs


VE-BEVS Insect Cell Lines


?VE-CL-01 Product No. 10010     ?VE-CL-02 Product No. 10020     ?VE-CL-03 Product No. 10030


Improved protein expression from the baculovirus expression vector system (BEVS) utilizing ParaTechs’ Vankyrin-Enhanced (VE) Sf9 insect cells. Further enhancement by using VE cells with our VE-transfer vector.


? Engineered monoclonal Sf9 cell line stably expresses a vankyrin gene


? Up to 14-fold increase in protein yield as compared to parental Sf9 cells


? Prolonged longevity of cells after infection with a BEVS


? Compatible with all conventional BEVS


? Reduced cost and labor


? Essentially no additional work or adaptation required


VE-CL-03細胞系 paratechs


ParaTechs offers three VE-insect cell lines for retail. Each of which has slightly different characteristics to help to enhance the expression of different types of recombinant protein.


VE-CL-03細胞系 paratechs


VE-CL-01 cells


Product number: 10010 Unit: 107cells/ml Price: $800


VE-CL-01 cell line


Sf9-derived cell line for the enhanced expression of highly stable intracellular and secreted proteins


This cell line offers a much prolonged expression time that greatlyenhances the yield of stable proteins. These cells are suitable for the expression of highly stable intracellular and secreted proteins. The cells are sold in batches of 1×107/ml cells in serum-free medium. Please note this product ships on dry ice so additional shipping charges may apply.


VE-CL-03細胞系 paratechs


VE-CL-02 cells


Product number: 10020 Unit: 107cells/ml Price: $800


VE-CL-02 cell line


Sf9-derived cell line for the enhanced expression of highly unstable or toxic proteins.


This cell line is recommended for laboratories working with highly unstable or toxic proteins as enhanced protein expression occurs at a very high level and over a very short time interval.


The cells are sold in batches of 1×107/ml cells in serum-free medium. Please note this product ships on dry ice so additional shipping charges may apply.


VE-CL-03細胞系 paratechs


VE-CL-03 cells


Product number: 10030 Unit: 107cells/ml Price: $800


VE-CL-03 cell line


Sf9-derived cell line for general enhancement of most recombinant proteins.


This cell line is recommended for the enhanced expression of proteins of unknown toxicity and stability or for general enhancement of most recombinant proteins expressed in conventional recombinant BEVS viruses.


The cells are sold in batches of 1×107/ml cells in serum-free medium. Please note this product ships on dry ice so additional shipping charges apply.


VE-BEVS Cell Line Instructions


VE-BEVS FAQs


VE-BEVS Licensing


Contract service for introducing the vankyrin gene into a custom insect cell line is available upon request.


Patent information:


VE-BEVS Cell Line United States Patent 7,842,493


VE-BEVS Transfer Vector United States Patent 7,629,160




正常肝細胞來源哪個細胞庫?



產品目錄 >>> RIKEN細胞庫


日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)


日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)


點擊看大圖


如果您對該產品感興趣的話,可以


給我留言


產品名稱: 日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)


產品型號: RIKEN


產品展商: RIKEN


美元($)價格: 0.00 元


歐元(€)價格: 0.00 元


人民幣(¥)價格: 0.00 元


產品文檔: 無相關文檔


發布時間:2018-06-20



簡單介紹


日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)簡稱理研,屬于文部科學省。是日本資本主義之父澀澤榮一于1917年設立的大型自然科學研究機構。二戰期間曾為日本核研究的研究機構。 日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)簡稱理研究領域包括物理、化學、生物學、工學、 醫學、生命科學、材料科學、信息科學等,從基礎研究到應用開發十分廣泛。RIKEN有大約3000 名研究人員,每年的預算約62億人民幣,大部分研究經費來自政府。1982年RIKEN與中國科學院締結了多方位的研究合作協議,很多中國研究人員在RIKEN從事研究工作,為中國科學技術的發展做出了貢獻。


日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)  的詳細介紹


Acris  abcam  cst  Biorbyt  santa  Novus  sigma  lifespan  NEB  roche  ABI  R&D millipore   BD  Qiagen Cayman  Jackson Life  GeneTex   Bio-Rad DSHB  tocris   peprotech 等品牌;部分產品現貨,超低比價,另常備  Trizol  DMSO  lipo2000    lipo3000  SC-2004  SC-2005常備現貨 ;貨期短,價格優,售后齊全。


日本理化學研究所RIKEN(RIkagaku KENkyusho/Institute of Physical and Chemical Research)簡稱理研,屬于文部科學省。是日本資本主義之父澀澤榮一于1917年設立的大型自然科學研究機構。二戰期間曾為日本核研究的研究機構。


其研究領域包括物理、化學、生物學、工學、 醫學、生命科學、材料科學、信息科學等,從基礎研究到應用開發十分廣泛。RIKEN有大約3000 名研究人員,每年的預算約62億人民幣,大部分研究經費來自政府。1982年RIKEN與中國科學院締結了多方位的研究合作協議,很多中國研究人員在RIKEN從事研究工作,為中國科學技術的發展做出了貢獻。


理化學研究所的本部位于埼玉縣和光市,在茨城縣筑波市、兵庫縣佐用郡、神奈川縣橫濱市、兵庫縣神戸市、宮城縣仙臺市、愛知縣名古屋市及東京都板橋區設有分所。


RIKEN是日本較大的綜合研究機構,以各種科學學科的高質量研究而聞名。RIKEN成立于1917年,作為東京的私人研究基金會,規模和規模日益壯大,今天在日本包括世界上等的研究中心和研究機構網絡。


RIKEN是日本科學研究中心的高調研究所,是各種科學學科領域的杰出世界領導者。其較先進的研究基礎設施和獨特的研究環境使其成為世界上較先進的研究機構之一,這是一個真正的國際研究中心,領導物理,生物學,醫學研究和工程基礎與應用研究的研究。


Cell No. Cell name General characteristics


AES0001   H-1   In vitro differentiation to various type tissue cells(e.g. neuron,cardiomyocyte,hematopoietic cells)  


AES0002   GS-DG1   Germline stem cell line derived from mouse testis.  


AES0003   B6G-2   Embryonic stem (ES) cell line derived from C57BL/6 mouse. Expressing GFP.  


AES0004   mGS-DBA1   Multipotent germline stem (mGS) cell line derived from mouse testis.  


AES0005   BRC1   Mouse embryonic stem cells derived from (B6xDBA2)x129 embryo.  


AES0006   BRC2   Mouse embryonic stem cells derived from (B6xDBA2)x(B6xDBA2) embryo.  


AES0007   BRC3   Mouse embryonic stem cells derived from (B6xDBA2)x(B6xDBA2) embryo.  


AES0008   BRC4   Mouse embryonic stem cells derived from C57BL/6 embryo.  


AES0009   BRC5   Mouse embryonic stem cells derived from C57BL/6 embryo. The karyotype is not normal.  


AES0010   BRC6   Mouse embryonic stem cells derived from C57BL/6 embryo (female) .  


AES0011   BRC7   Mouse embryonic stem cells derived from C57BL/6 embryo.  


AES0012   BRC8   Nuclear transferred mouse embryonic stem cells. Nucleus was derived from (B6xDBA2) mouse.  


AES0013   BRC9   Nuclear transferred mouse embryonic stem cells. Nucleus was derived from (B6xDBA2) mouse.  


AES0014   TT2   Mouse ES cell line (B6 X CBA). This cell line can be used only for in vitro culture experiment.  


AES0015   BDmt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x DBA2). Feeder-free cell line  


AES0016   BDmt-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x DBA2). Feeder-free cell line.  


AES0017   BDft-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x DBA2). Feeder-free cell line.  


AES0018   BDfc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x DBA2). Feeder-free cell line.  


AES0020   BCmt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x C3H/He). Feeder-free cell line  


AES0021   BCmt-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse (C57BL/6 x C3H/He). Feeder-free cell line.  


AES0022   BCft-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x C3H/He). Feeder-free cell line  


AES0024   BCfc-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse (C57BL/6 x C3H/He). Feeder-free cell line.  


AES0025   BD129mt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  


AES0026   BD129mt-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 male mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  


AES0027   BD129fc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  


AES0028   BD129fc-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 female mouse ((C57BL/6 x DBA2) x 129/Sv). Feeder-free cell line.  


AES0029   C3Hmt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He male mouse. Feeder-free cell line.  


AES0030   C3Hft-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  


AES0031   C3Hft-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  


AES0032   C3Hfc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C3H/He female mouse. Feeder-free cell line.  


AES0033   B6mt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 male mouse. Feeder-free cell line.  


AES0034   B6mt-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 male mouse. Feeder-free cell line.  


AES0035   B6ft-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  


AES0036   B6ft-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  


AES0037   B6fc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  


AES0038   B6fc-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from C57BL/6 female mouse. Feeder-free cell line.  


AES0039   DBAmt-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 male mouse. Feeder-free cell line.  


AES0040   DBAmt-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 male mouse. Feeder-free cell line.  


AES0041   DBAfc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 female mouse. Feeder-free cell line.  


AES0042   DBAfc-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from DBA/2 female mouse. Feeder-free cell line.  


AES0043   129fc-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from 129/Sv female mouse. Feeder-free cell line.  


AES0044   129fc-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from 129/Sv female mouse. Feeder-free cell line.  


AES0045   FVB-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from FVB male mouse. Feeder-free cell line.  


AES0049   ICRft-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from ICR male mouse. Feeder-free cell line.  


AES0050   OKM-4   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from ICR hermaphrodite mouse. Feeder-free cell line.  


AES0051   BDmto-1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 (C57BL/6 x DBA2) male aged mouse. Feeder-free cell line.  


AES0052   BDmto-2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus was derived from F1 (C57BL/6 x DBA2) male aged mouse. Feeder-free cell line.  


AES0054   EBRTcH3   Mouse embryonic stem cell line. Convenient to establish the line carrying an inducible expression unit (see reference). Feeder-free cell line.  


AES0118   NOD·ESA   Mouse embryonic stem (ES) cell line derived from NOD mouse.  


AES0119   EBRTcH3(serum)   Mouse embryonic stem (ES) cell line derived from 129/Ola mouse. Feeder-free cell line  


AES0120   Fbx15^(βgeo/βgeo)ES   A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse) lacking Fbx15 expression. Fbx15 gene was replaced with βgeo gene in both alleles.  


AES0121   Nanog^(βgeo/+)ES   A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse). Nanog gene was replaced with βgeo gene in one allele.  


AES0125   2TS22C   Mouse embryonic stem cells derived from 129/Ola male mouse. Feeder-free cell line  


AES0126   Nanog^(βgeo/Hyg)   A subline of mouse embryonic stem cell (RF8 derived from 129 SV Jae strain mouse) lacking Nanog expression. Nanog genes were replaced with βgeo gene in one allele and hygromycin resistant gene in another allele. Feeder-free cell line.  


AES0127   TCNT1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (T-cell) was derived from F1 (C57BL/6 x 129) male mouse.  


AES0128   HSNT1   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (Hematopoietic stem cell) was derived from F1 (C57BL/6 x 129) male mouse.  


AES0129   HSNT2   Mouse embryonic stem (ES) cell line established by nuclear transfer technique. Nucleus (Hematopoietic stem cell) was derived from F1 (C57BL/6 x 129) male mouse.  


AES0130   BXM3   Mouse embryonic stem (ES) cell line derived from F1 mouse (C57BL/6 x MSM).  


AES0131   BXM7   Mouse embryonic stem cell line derived from F1 mouse (C57BL/6 x MSM).  


AES0132   BXM14   Mouse embryonic stem cells derived from F1 mouse (C57BL/6 x MSM).  


AES0133   BXM15   Mouse embryonic stem cells derived from F1 mouse (C57BL/6 x MSM).  


AES0134   EGFP-MBD-nls   Mouse embryonic stem cells derived from 129/Ola male mouse. The methylated DNA binding domain (MBD) and the nuclear localization signal (nls) sequence coding for human methyl CpG-binding domain protein 1 (MBD1) were fused to the enhanced green fluorescent protein (EGFP) reporter gene, and ES cell lines carrying the construct ( EGFP-MBD-nls ) were established. Feeder-free cell line  


AES0135   E14tg2a   Mouse embryonic stem (ES) cell line derived from 29/Ola.  


AES0136   ZHBTc4   Mouse ES cell line derived from ZHTc6 and maintained by tetracycline(Tc)-regulatable Oct-3/4 transgene. Both of Oct-3/4 locus are disrupted by IRES-zeocin and IRES-BSD KO vectors. It should be cultured in the absence of tetraycline to maintain the undifferentiated state. See reference regarding more precise information.  


AES0137   ZHTc6   Mouse ES cell line derived from 129/Ola. It should be cultured in the presence of tetracycline to maintain the undifferentiated state. See reference regarding more precise information.  


AES0139   EB3   Mouse embryonic stem cell line derived from 129/Ola strain. Oct3/4 gene was replaced with 'ires-blasticidin S registant gene' in one allele. Feeder-free cell line. Feeder-free cell line.  


AES0140   B6J-S1^(UTR)   Mouse ES cell line derived from C57BL/6J.  


AES0141   B6NJ-22^(UTR)   Mouse ES cell line derived from F1 (C57BL/6NCrlCrlj x C57BL/6J).  


AES0143   B6J-23^(UTR)   Mouse ES cell line derived from C57BL/6J.  


AES0144   B6N-22^(UTR)   Mouse ES cell line derived from C57BL/6NCrlCrlj.  


AES0145   Rx-GFP K/I EB5   A subline of mouse embryonic stem cell line, EB5 (129/Ola), in which GFP gene is knocked-in under Rx promoter.  


AES0146   Dnmt1-/-Dnmt3a-/-Dnmt3b-/- ES (clone19)   Mouse ES cell line lacking all of Dnmt1, Dnmt3a and Dnmt3b. Derived from 129Sv/Jae.  


AES0147   aBJ-2   Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  


AES0148   aBJ-3   Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  


AES0149   aBJ-4   Mouse androgenetic embryonic stem (ES) cell line. C57BL/6Cr x JF1  


AES0150   G4-2   Mouse embryonic stem (ES) cell line derived from 29/Ola. Expressing GFP.  


AES0151   EB5   Mouse embryonic stem cell line derived from 129/Ola. Feeder-free cell line.  


AES0152   OCRG9   Mouse embryonic stem cell line derived from 129/Ola.  


AES0153   OLV2-1   Mouse embryonic stem (ES) cell line derived from 129/Ola. The expression of Oct3/4 can be detected as the expression of Venus.  


AES0154   OLC2-1   Mouse embryonic stem (ES) cell line derived from 129/Ola. The expression of Oct3/4 can be detected as the expression of ECFP.  


AES0161   Dnmt1-/- ES (clone 36)   Mouse ES cell line lacking Dnmt gene.  


AES0164   Dnmt3a-/- ES (clone 6aa)   Mouse ES cell line lacking Dnmt3a gene.  


AES0165   Dnmt3b-/- ES (clone 8bb)   Mouse ES cell line lacking Dnmt3b gene.  


AES0166   CMES40   Embryonic stem (ES) cell line derived from common marmoset (Callithrix jacchus). Common marmoset is one of the animals as the object of Convention on International Trade in Endangered Species (CITES). Therefore, according to the CITES the permissions of the regulatory bodies are necessary in both exporting and importing countries.  


AES0172   B6-6   Mouse ES cell line derived from C57BL/6NCrSlc. Contribution to chimeras and germilne transmission have been confirmed.  


AES0173   Bf1-Venus K/I EB3   A subline of mouse ES cell line, EB3, in which Venus gene is knocked-in in the Bf1(Foxg1) locus.  


AES0174   rdES2-1   Rabbit embryonic stem (ES) cell line.Application consideration  


AES0175   rdES4   Rabbit embryonic stem cell line. Application consideration  


AES0176   Etv2-Venus-KI   Mouse embryonic stem (ES) cell line, Etv2-Venus-KI (see reference).  


AES0177   Etv2-Venus-KO   Mouse embryonic stem (ES) cell line, Etv2-Venus-KO (see reference).  


AES0182   EGR-G101   Mouse embryonic stem (ES) cell line derived from C57BL/6NCr. Expressing EGFP.  


AES0184   EGR-101   Mouse embryonic stem (ES) cell line derived from C57BL/6N.  


AES0186   BRC6(feeder-free)   Mouse embryonic stem (ES) cell line derived from C57BL/6NCrSlc. Feeder-free cell line (AES0010 BRC6).  


AES0187   B6-6(feeder-free)   Mouse embryonic stem (ES) cell line derived from C57BL/6NCrSlc. Feeder-free cell line (AES0172 B6-6).  


AES0190   NAT1(+/-)ES(A7)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  


AES0191   NAT1(+/-)ES(B4)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  


AES0192   NAT1(+/-)ES(C1)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient heterogeneously.  


AES0193   NAT1(-/-)ES(B2)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  


AES0194   NAT1(-/-)ES(B12)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  


AES0195   NAT1(-/-)ES(C3)   Mouse embryonic stem (ES) cell. NAT1 gene is deficient homogeneously.  


AES0196   Mvh-Venus GS   This GS cell line was derived from testis of new born transgenic mouse, Tg(Mvh-Venus)1Rbrc, carrying Venus gene inserted into the 2nd exon of Mouse Vasa Homolog (Mvh or alternatively called Ddx4) gene. Mvh gene is known to be specifically expressed in male and female germ cells.  


AES0197   Mili-KO GS   Mouse germline stem (GS) cell lacking Mili gene.  


AES0204   EpiSC 129Ba1   Mouse Epiblast Stem cells (EpiSCs) established in the presence of Wnt secretion inhibitor, IWP-2. The cell line was derived from embryos obtained by 129S2/Sv x C57BL/6N cross. Homogeneous cellular state can be maintained in the culture medium containing IWP-2.  


AES1232   26v-006   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-006.  


AES1233   26v-009   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-009.  


AES1240   26v-023   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_26v-023.  


AES1384   33v1-051   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese.  


AES1397   36v-38   The Gene-trap Mouse ES cell (V6.4) clone. Mus musculus mRNA. The NAISTrap data bese : NAISTrap_36v-38.  


AES1421   37v-42   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_37v-42.  


AES1519   38v-29   The Gene-trap Mouse ES cell (V6.4) clone. The NAISTrap data bese : NAISTrap_38v-29.  


AES1913   2TP-084   The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID:unknown  


AES2228   TPM2-187   The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_012060  


AES2486   TPM5-123   The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_001081417  


AES2641   TPM6-180   The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_177691  


AES2764   TPM6-360   The Gene-trap Mouse ES cell (V6.4) clone. Misc_ID: NM_010158  


APS0001   iPS-MEF-Ng-20D-17   Mouse induced pluripotent stem (iPS) cell line. Expressing GFP by Nanog promoter. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0002   iPS-MEF-Ng-178B-5   Mouse iPS cell line established with three factors, Oct3/4, Sox2 and Klf4, using retrovirus vector. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0003   iPS-MEF-Fb/Ng-440A-3   Mouse iPS cell line established without retrovirus vector. It has no integration of exogene. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0004   iPS-MEF-Ng-492B-4   Mouse iPS cell line established without retrovirus vector. It has no integration of exogene. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0005   iPS-Stm-FB/gfp-99-1   Mouse iPS cell line derived from stomach cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0006   iPS-Stm-FB/gfp-99-3   Mouse iPS cell line derived from stomach cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0007   iPS-Hep-FB/Ng/gfp-103C-1   Mouse iPS cell line derived from liver cells. Expressing GFP by CAG promoter. βgeo is knocked-in at Fbx15 locus. GFP and puromycin resistant gene can be expressed by Nanog promoter. Order Form ( C-0033, C-00034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


APS0008   iPS-L1   Rabbit induced pluripotent stem (iPS) cell line. Application consideration. Order Form ( C-0033, C-00007 or C-0007p).  


APS0009   iPS-L2   Rabbit induced pluripotent stem (iPS) cell line. Order Form ( C-0033, C-00007 or C-0007p).  


APS0010   iPS-S1   Rabbit induced pluripotent stem (iPS) cell line. Application consideration. Order Form ( C-0033, C-00007 or C-0007p).  


APS0011   iPS-S2   Rabbit induced pluripotent stem (iPS) cell line. Order Form ( C-0033, C-00007 or C-0007p).  


GMC0001   B0082   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0002.  


GMC0002   A0082   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0001.  


GMC0003   B0006   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0004   A0065   Human primary adherent cells derived from Werner syndrome (questionable) patient's skin.  


GMC0005   B0031   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0012.  


GMC0006   WS2RGB   Accelerated aging in vitro, Werner's syndrome  


GMC0007   WS3RGB   Accelerated aging in vitro, Werner's syndrome.  


GMC0009   WS6RGB   Werner's syndrome fibroblast  


GMC0010   UN7RGB   Questionable Werner's syndrome-like. Life span in vitro was over 60 PDL.  


GMC0011   UN8RGB   Once thought Werner's Syndrome, but the life span in vitro was more than 50 PDL.  


GMC0012   A0031   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0005.  


GMC0013   B0096   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0014   A0042   Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0015.  


GMC0015   B0042   Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0014.  


GMC0016   B0022   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0017   B0055   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.The same patient as GMC0022.  


GMC0019   B0090   Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus.  


GMC0020   B0072   Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0024.  


GMC0021   A0022   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0016.  


GMC0022   A0055   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00017.  


GMC0023   B0036   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0024   A0072   Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0020.  


GMC0025   B0010   Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0027.  


GMC0026   B0076   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0027   A0010   Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0025.  


GMC0028   A0058   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0029.  


GMC0029   B0058   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. he same patient as GMC0028.  


GMC0030   B0050   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0031.  


GMC0031   A0050   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0030.  


GMC0032   B0078   Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus.  


GMC0033   B0086   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0034   B0045   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.  


GMC0035   B0026   Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0036.  


GMC0036   A0026   Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00035.  


GMC0037   A0001   Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0038.  


HES0001   KhES-1   Human embryonic stem cell line.  


HES0002   KhES-2   Human embryonic stem cell line.  


HES0003   KhES-3   Human embryonic stem cell line.  


HES0004   KhES-4   Human embryonic stem cell line.  


HES0005   KhES-5   Human embryonic stem cell line.  


HES0006   SEES1   Human embryonic stem cell line.  


HES0007   SEES2   Human embryonic stem cell line.  


HES0008   SEES3   Human embryonic stem cell line.  


HPS0002   253G1   Human iPS cell line. HPS0063 and HPS0076 were derived from the same patient. Order Form ( C-0042, C-0034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


HPS0003   HiPS-RIKEN-1A   Human iPS cell line. Parent cell line of RCB0436 HUC-F2. Order Form (C-0042, C-0007 or C-0007p).  


HPS0009   HiPS-RIKEN-2A   Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Order Form (C-0042, C-0007 or C-0007p).  


HPS0014   HiPS-RIKEN-2F   Human iPS cell line. Parent cell line of RCB0197 HUC-Fm. Order Form (C-0042, C-0007 or C-0007p).  


HPS0029   HiPS-RIKEN-12A   Human iPS cell line. Order Form (C-0042, C-0007 or C-0007p).  


HPS0045   HiPS-RIKEN-5A   Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0395 NCU-F8). Order Form (C-0042, C-0006, C-0007 or C-0007p).  


HPS0049   HiPS-RIKEN-7A   Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0390 NCU-F3). Order Form (C-0042, C-0006, C-0007 or C-0007p).  


HPS0053   HiPS-RIKEN-9A   Disease specific iPS cell line derived from a patient of Wilson's disease (RCB0391 NCU-F4). Order Form (C-0042, C-0006, C-0007 or C-0007p).  


HPS0059     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  


HPS0060     Disease specific iPS cell line derived from a patient : Dementia of Alzheimer??s type. HPS0812 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  


HPS0061   59M8   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0062   K10M5   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0063   201B7   Human iPS cell line. HPS0002 and HPS0076 were derived from the same patient.Order Form ( C-0042, C-0034). Please see CiRA , Kyoto University if you are a researcher at a for–profit organization.  


HPS0064     Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 1b. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0070     Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0071 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0071     Disease specific iPS cell line derived from a patient : Mitochondrial myopathy, Encephalopathy, Lactic acidosis, and Stroke-like episodes. HPS0070 was derived from the same patient.iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0072   K11PD17   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0073   K21S4   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0007 or C-0007p).  


HPS0074   K31M28   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0075   K32M17   Disease specific iPS cell line derived from a patient : Pigmentary degeneration of the retina. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0076   409B2   Human iPS cell line. HPS0002 and HPS0063 are derived from the same person. Order Form ( C-0042, C-0034).  


HPS0077   454E2   Human iPS cell line. Application consideration. Order Form ( C-0042, C-0034).  


HPS0078     Disease specific iPS cell line derived from a patient : Bernard-Soulier syndorome. Order Form (C-0042, C-0007 or C-0007p).  


HPS0082   iPWS5   Disease specific iPS cell line derived from a patient : Prader Willi syndrome(RCB1560 PWS-Yamaguchi). del(15) was found in lymphocytes of the patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0007 or C-0007p).  


HPS0083   iCK2   Disease specific iPS cell line derived from a patient : Cockayne's syndrome(RCB0397 NCU-F10). HPS0085 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0085   iCK10   Disease specific iPS cell line derived from a patient : Cockayne's syndrome(RCB0397 NCU-F10). HPS0083 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0087   iOTC4   Disease specific iPS cell line derived from a patient : Ornithinetranscarbamylase deficiency (RCB0492 OTCD1TKB). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0097     Disease specific iPS cell line derived from a patient : Parkinson's disease, Familial type, PARK2. Order Form (C-0042, C-0007 or C-0007p).  


HPS0117   CiRA086Ai-m1   Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). Application consideration. Order Form (C-0042, C-0057, C-0007).  


HPS0119   CiRA188Ai-M1   Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0120 was derived from the same patient. Application consideration. Order Form (C-0042, C-0057, C-0007).  


HPS0120   CiRA188Ai-W1   Disease specific iPS cell line derived from a patient : Chronic infantile neurological cutaneous and articular (CINCA) syndrome (somatic mosaicism). HPS0119 was derived from the same patient. Application consideration. Order Form (C-0042, C-0057, C-0007).  


HPS0129     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (classical, with UMN). HPS0130 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0130     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (classical, with UMN). HPS0129 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0133     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Miyoshi type (Miyoshi myopathy). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0134     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (pseudo-polyneuritic, w/o UMN). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0136     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (pseudo-polyneuritic, w/o UMN). HPS0134 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0140     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Familial type. HPS0141 and HPS0142 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0142     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Familial type. HPS0140 and HPS0141 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0143     Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0144 and HPS0145 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0144     Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0143 and HPS0145 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0145     Disease specific iPS cell line derived from a patient : Congenital fiber type disproportion disease. HPS0143 and HPS0144 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0146     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (bulbar, with UMN). HPS0147 and HPS0148 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0147     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (bulbar, with UMN). HPS0146 and HPS0148 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0148     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis, Sporadic type (bulbar, with UMN). HPS0146 and HPS0147 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0149   iTS1   Disease specific iPS cell line derived from a patient : Tay-Sachs' disease (RCB0697 GM2-1TKB). iPS cells were created using the Sendai virus vector. HPS0150 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0150   iTS2   Disease specific iPS cell line derived from a patient : Tay-Sachs' disease (RCB0697 GM2-1TKB). iPS cells were created using the Sendai virus vector. HPS0149 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0156     Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0157 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0157     Disease specific iPS cell line derived from a patient : Bardet-Biedl syndrome. HPS0156 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0158     Disease specific iPS cell line derived from a patient : Spinal muscular atrophy type 1. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0164     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0169     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0171 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0171     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0169 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0174     Disease specific iPS cell line derived from a patient : Dermatomyositis (DM). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0175     Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 2. HPS0176 and HPS0177 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0176     Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 2. HPS0175 and HPS0177 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0177     Disease specific iPS cell line derived from a patient : Glycogen storage disease, Type 2. HPS0175 and HPS0176 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0178     Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), HPS0180 was derived from the same patient. Systematic Sclerosis (SSc). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0180     Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), HPS0178 was derived from the same patient. Systematic Sclerosis (SSc). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0183     Disease specific iPS cell line derived from a patient : Inclusion body myositis. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0184     Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0185 and HPS0186 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0185     Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0184 and HPS0186 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0186     Disease specific iPS cell line derived from a patient : Progressive systemic sclerosis (PSS), Systematic Sclerosis (SSc). HPS0184 and HPS0185 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0191     Disease specific iPS cell line derived from a patient : Bernard-Soulier syndrome. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0192     Disease specific iPS cell line derived from a patient : Allergic rhinitis (Pollen allergy). Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0200     Disease specific iPS cell line derived from a patient :Muscular dystrophy, Limb-girdle type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0207     Disease specific iPS cell line derived from a patient : X-Linked α-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0209     Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0211 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0211     Disease specific iPS cell line derived from a patient : Pulmonary hypertension. HPS0209 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0214     Disease specific iPS cell line derived from a patient : Ehlers-Danlos syndrome, Kosho Type. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0215     Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0217 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0217     Disease specific iPS cell line derived from a patient : Moyamoya disease. HPS0215 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0223   Nips-B2   Human iPS cell line. iPS cells were created using the Sendai virus vector. Past history : atopic asthma. Order Form(C-0042, C-0007 or C-0007p).  


HPS0224     Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0226 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0226     Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0224 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0227     Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0228 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0228     Disease specific iPS cell line derived from a patient : Amyloid neuropathy, Familial type. HPS0227 was derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0233     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Becker type. HPS0234 was derived from the same patient.iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0234     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Becker type. HPS0233 was derived from the same patient.iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0240     Disease specific iPS cell line derived from a patient : Metachromatic leukodystrophy (MLD). iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0247     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  


HPS0248     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  


HPS0249     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  


HPS0254     Disease specific iPS cell line derived from a patient : Alzheimer disease. Order Form (C-0042, C-0057, C-0007).  


HPS0255     Disease specific iPS cell line derived from a patient : Alzheimer disease. Order Form (C-0042, C-0057, C-0007).  


HPS0256     Disease specific iPS cell line derived from a patient : Alzheimer disease. Order Form (C-0042, C-0057, C-0007).  


HPS0263     Disease specific iPS cell line derived from a patient : Huntington??s disease. Order Form (C-0042, C-0057, C-0007).  


HPS0264   CiRA-PD00021   Disease specific iPS cell line derived from a patient : Parkinson's disease. Order Form (C-0042, C-0057, C-0007).  


HPS0265     Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0266 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0266     Disease specific iPS cell line derived from a patient : Adenosine deaminase deficiency (ADA). HPS0265 was derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0270     Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0271 and HPS0272 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0271     Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0270 and HPS0272 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0272     Disease specific iPS cell line derived from a patient : Atopic dermatitis. HPS0270 and HPS0271 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0288   iPS-WS2-C5   Disease specific iPS cell line derived from a patient : Werner syndrome. Order Form (C-0042, C-0057, C-0007).  


HPS0290   CiRA00022   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0291 and HPS0327 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0291   CiRA00023   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0290 and HPS0327 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0292   CiRA00024   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0293 and HPS0294 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0293   CiRA00025   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0292 and HPS0294 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0294   CiRA00026   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0292 and HPS0293 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0312     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0313 and HPS0314 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0313     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0314 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0314     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0312 and HPS0313 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0317     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0319, HPS0322 and HPS0323 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0319     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0322 and HPS0323 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0322     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0319 and HPS0323 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0323     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type (manifesting carrier). The source of this cell line is fibroblasts derived from skeletal muscle tissue. HPS0317, HPS0319 and HPS0322 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0327   CiRA00021   Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. HPS0290 and HPS0291 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0328   606A1   Human iPS cell line derived from a healthy individual (cord blood) . Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc and Lin28 were used for establishment. Order Form ( C-0042, C-0034).  


HPS0331   610B1   Human iPS cell line derived from a healthy individual (cord blood) . Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc and Lin28 were used for establishment. Order Form ( C-0042, C-0034).  


HPS0332     Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Order Form (C-0042, C-0057, C-0007).  


HPS0333     Disease specific iPS cell line derived from a patient : Hypophosphatasia, perinatal type. Order Form (C-0042, C-0057, C-0007).  


HPS0334     Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0335 and HPS0336 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0335     Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0334 and HPS0336 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0336     Disease specific iPS cell line derived from a patient : Chronic granulomatous disease (CGD), p47phox-deficiency. HPS0334 and HPS0335 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0337     Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0338 and HPS0339 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0338     Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0339 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0339     Disease specific iPS cell line derived from a patient : X-linked Chronic granulomatous disease (X-CGD), gp91phox-deficiency). HPS0337 and HPS0338 were derived from the same patient. iPS cells were created using the Sendai virus vector. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0351   VCP-#1   Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0352 and HPS0353 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0352   VCP-#2   Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0353 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0353   VCP-#4   Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0352 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).  


HPS0360   648A1   Human iPS cell line derived from a healthy individual (peripheral blood)l. Established with episomal vector and no exogenous gene is present in the cell line. Oct3/4, Sox2, Klf4, L-Myc, Lin28 and shRNA against p53 were used for establishment. Order Form ( C-0042, C-0034).  


HPS0376   CiRA00041   Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0377 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0377   CiRA00042   Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP).HPS0376 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0378   CiRA00043   Disease specific iPS cell line derived from a patient : Fibrodysplasia ossificans progressiva (FOP). Order Form (C-0042, C-0057, C-0007).  


HPS0383   CiRA00111   Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. HPS0854, HPS0385, HPS0386 and HPS0387 were derived from the same patient.PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  


HPS0384   CiRA00111-IF-D28   Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0385, HPS0386 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  


HPS0385   CiRA00111-ES-H19   Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0386 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  


HPS0386   CiRA00111-TKI-I15   Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0387 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  


HPS0387   CiRA00111-CKI-C2   Disease specific iPS cell line derived from a patient : Muscular dystrophy, Duchenne type. Correction of the dystrophin gene. HPS0383, HPS0384, HPS0385 and HPS0386 were derived from the same patient. PMID: 25434822. Order Form (C-0042, C-0057, C-0007).  


HPS0388     Disease specific iPS cell line derived from a patient : Achondroplasia.  


HPS0390     Disease specific iPS cell line derived from a patient : Miyoshi myopathy.  


HPS0393     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy.  


HPS0395     Disease specific iPS cell line derived from a patient : Muscular dystrophy, Myotonic Dystrophy.  


HPS0397     Disease specific iPS cell line derived from a patient : Miyoshi myopathy.  


HPS0407     Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. HPS1010 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  


HPS0408     Disease specific iPS cell line derived from a patient : Miyoshi myopathy.  


HPS0414     Disease specific iPS cell line derived from a patient :Primary lateral sclerosis (PLS).  


HPS0419     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0057, C-0007).  


HPS0426   CiRA00139   Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  


HPS0429   CiRA00142   Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  


HPS0458     Disease specific iPS cell line derived from a patient : Mitochondrial encephalomyopathy. Order Form (C-0042, C-0057, C-0007).  


HPS0470     Disease specific iPS cell line derived from a patient : Frontotemporal dementia. Order Form (C-0042, C-0057, C-0007).  


HPS0473     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0007).  


HPS0476     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0007).  


HPS0482     Disease specific iPS cell line derived from a patient : Spinal-Bulbar Muscular Atrophy (SBMA). Order Form (C-0042, C-0057, C-0007).  


HPS0485     Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis. Order Form (C-0042, C-0007).  


HPS0488     Disease specific iPS cell line derived from a patient : Niemann-Pick disease, Type C variant biochemical phenotype. HPS0489 and HPS0490 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0489     Disease specific iPS cell line derived from a patient : Niemann-Pick disease, Type C variant biochemical phenotype. HPS0488 and HPS0490 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0490     Disease specific iPS cell line derived from a patient : Niemann-Pick disease, Type C variant biochemical phenotype. HPS0488 and HPS0489 were derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS0507   CiRA00160   Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  


HPS0508   CiRA00161   Disease specific iPS cell line derived from a patient :Charcot-Marie-Tooth disease .  


HPS0522   CiRA00169   Disease specific iPS cell line derived from a patient :Achondroplasia. HPS0523 was derived from the same patient.  


HPS0523   CiRA00170   Disease specific iPS cell line derived from a patient :Achondroplasia. HPS0522 was derived from the same patient.  


HPS0525     Disease specific iPS cell line derived from a patient : Osteogenesis Imperfecta.  


HPS0540     Disease specific iPS cell line derived from a patient :Muscular dystrophy, Myotonic Dystrophy.  


HPS0546     Disease specific iPS cell line derived from a patient : Mucopolysaccharidosis (MPS)VI. Order Form (C-0042, C-0057, C-0007).  


HPS0772     Disease specific iPS cell line derived from a patient : Multiple system atrophy (MSA). Order Form (C-0042, C-0057, C-0007).  


HPS0939     Disease specific iPS cell line derived from a patient :Achondroplasia.  


HPS0945     Disease specific iPS cell line derived from a patient :Osteogenesis Imperfecta.  


HPS0953     Disease specific iPS cell line derived from a patient :Achondroplasia.  


HPS1010     Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. HPS0407 was derived from the same patient.Order Form (C-0042, C-0057, C-0007).  


HPS1011     Disease specific iPS cell line derived from a patient :Familial central diabetes insipidus. Order Form (C-0042, C-0057, C-0007).  


HPS1012     Disease specific iPS cell line derived from a patient :Best disease. Order Form (C-0042, C-0057, C-0007).  


HPS1013     Disease specific iPS cell line derived from a patient :Gelatinous drop-like corneal dystrophy. Order Form (C-0042, C-0057, C-0007).  


HPS1072     Disease specific iPS cell line derived from a patient :Age related Macular degeneration. Order Form (C-0042, C-0057, C-0007).  


HPS1478     Disease specific iPS cell line derived from a patient : Hunter syndorome, recombination of IDS preudogene. Order Form (C-0042, C-0057, C-0007).  


HPS1725     Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration. Order Form (C-0042, C-0057, C-0007).  


HPS1728     Disease specific iPS cell line derived from a patient : Epilepsy. Order Form (C-0042, C-0057, C-0007).  


HPS1745   CiRA00003   Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1747 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS1746   CiRA00455   Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS0254 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS1747   CiRA00002   Disease specific iPS cell line derived from a patient : Alzheimer disease. HPS1745 was derived from the same patient. Order Form (C-0042, C-0057, C-0007).  


HPS2220     Disease specific iPS cell line derived from a patient : Myasthenia gravis positive for anti AChR antibody. Order Form (C-0042, C-0057, C-0007).  


RCB0001   Vero   No interferon production, best for vaccine product. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0002   ARM193   Anti-recA protein mAb (IgG2b)  


RCB0005   BALB/3T3 clone A31   Contact-inhibited semi-normal cell line  


RCB0007   HeLa   Just like atcc CCL 2, HeLa  


RCB0008   V79   Chinese hamster lung fibroblast  


RCB0009   PC-12   Pheochromocytoma, differentiate by NGF stimulation  


RCB0012   M227   Infected with ts mutant of Kirsten sarcoma virus  


RCB0016   CCRF-HSB-2   T cell leukemia  


RCB0026   PAb1400   Anti-SV40 large T antigen mAb (IgG)  


RCB0027   K562   Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .  


RCB0032   FM3A FT-101   Temperature-sensitive, forms multiple nuclei  


RCB0033   FM3A tscl.T85 Tsai   Temperature-sensitive at chromosome condensation  


RCB0034   FM3A ts T244   Temperature-sensitive at DNA polymerase  


RCB0035   WEHI-3   Secrete growth factors for hematpoietic stem cells  


RCB0036   C127   Host for bovine papiloma virus  


RCB0041   HL60   Differentiate to granulocytes and monocytes  


RCB0043   NRK   Contact-inhibited semi-normal, original of NRK49F  


RCB0056   NIH3T3/14-1   Spontaneous transformant of NIH3T3  


RCB0057   NIH3T3/13C7   SV40 large T (tsA58)-pBR322 transformed NIH3T3.  


RCB0063   JTC-15   Subclone of AH-66, lost transplantability in rats.  


RCB0065   JTC-27   Ascites hepatoma.  


RCB0067   M   Capable to form collagen network  


RCB0069   RLC-16   Epithelial cell from rat liver  


RCB0070   RLC-18   Non tumorigenic in nude mice  


RCB0072   RLC-27   Liver-derived cell, tumorigenic in nude mice  


RCB0074   JTC-19   Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.  


RCB0075   RCR-1   Astroglia cell line  


RCB0076   LYM-1   Sticky cell from lymph node.  


RCB0083   HLC-1   Lung adenocarcinoma  


RCB0086   FM3A   Mammary carcinoma, grow in vitro and in vivo  


RCB0095   P3·NS-1/1·Ag4.1   Myeloma  


RCB0096   Don(D-6)   Pseudodiploid, two marker chromosomes  


RCB0097   CHL   Widely used in chromosome aberration test  


RCB0098   A549   Lung carcinoma, refer to ATCC CCL185  


RCB0101   L·P3   Protein- & lipid-free medium growing  


RCB0102   IC-2   Mast cell precursor, respond to IL-3. Conditioned medium.  


RCB0112   NRK49F   Contact-inhibited semi-normal cell line  


RCB0115   ARM321   Anti-recA protein mAb (IgG1)  


RCB0116   7501   S. cerevisiae Endo.Sce I large subunit mAb (IgG2b)  


RCB0120   LT4Tr   Spontaneous transformant of LT4  


RCB0135   L5178Y   Rapidly growing lymphoma  


RCB0136   M10   Highly sensitive to X-ray irradiation  


RCB0137   M10^(-)   Resistant to 6TG, isolated from M10  


RCB0138   LX830   Highly sensitive to X-ray irradiation  


RCB0142   Ehrlich   Ehrlich's ascite tumor  


RCB0143   COS-1   SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0146   P3-X63-Ag8.653   Myeloma  


RCB0153   HUC-F   Normal umbilical cord fibroblast, female  


RCB0156   305M   Normal human skin fibroblast  


RCB0159   HS-K   Normal diploid fibroblast from Japanese  


RCB0160   CV-1   Highly susceptible to SV40 infection. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0162   NHSF46   Diploid fibroblast from normal Japanese skin.  


RCB0163   RGB3T3-1   Original cloned line from RCB, just like BALB/3T3  


RCB0164   RGB3T3-5   Siblings of RGB3T3-1, contact-inhibited  


RCB0165   REF-RGB   Suitable as feeders for hybridoma cloning  


RCB0169   M1   Differentiate to macrophage and granulocyte  


RCB0171   7T1   Contact inhibited, may transform spontaneously  


RCB0174   SUSM-1   Transformed in vitro with carcinogen  


RCB0180   MDBK   Kidney epithelial cell, equiv. to ATCC CRL6071  


RCB0183   RK13   Susceptible to rubella virus, equiv. to ATCC CCL37  


RCB0184   OLF-136   Fish (medaka) fin fibroblast. Application consideration  


RCB0185   CAEP   Gold fish erythrophoroma with 4n chromosomal mode  


RCB0186   CAF   Pinna fibroblast  


RCB0187   OLHE-131   H04C medaka hepatoma pretreated with MAM-acetate. Application consideration  


RCB0188   OLME-104   HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Cell growth is slow. Application consideration  


RCB0191   HeLa.S3   Most famous cultured human cell line  


RCB0193   KMM-1   Human myeloma. Lambda- chain producing.  


RCB0195   PAb419   Anti-SV40 large T antigen mAb (IgG)  


RCB0197   HUC-Fm   Normal umbilical cord fibroblast, male  


RCB0202   A431   High level of EGF receptor  


RCB0205   BU25 TK-   Thymidine kinase defective HeLa  


RCB0206   MOLT-4   T cell leukemia, the same patient as RCB1164 MOLT-3.  


RCB0207   MRC-5 SV1 TG1   SV40-transformed, 6TG-resistant and HAT-sensitive.  


RCB0208   LTK-   Thymidine kinase defective L cell  


RCB0209   SP2/0-Ag14   Myeloma  


RCB0210   HF19   Normal human lung fibroblast.  


RCB0211   MRC-5   Normal embryonic lung fibroblast.  


RCB0212   CT14-G4   Anti human c-myc p62 mAb (IgG1.kappa)  


RCB0213   NS0   Myeloma. Application consideration  


RCB0218   MRC-5, known PDL   Normal embryonic lung fibroblast with accurate PDL  


RCB0222   NB1RGB   Normal human skin fibroblast, RCB original  


RCB0224   ST2   Bone marrow stroma cell-derived  


RCB0243   Nil2C2   Highly metastatic sarcoma  


RCB0244   Nil2C1   Highly metastatic sarcoma  


RCB0245   Nil1C1   Highly metastatic sarcoma, synthesize hematoside  


RCB0247   10T1/2   Clone 8, Contact-inhibited semi-normal  


RCB0248   3T6   Non-contact inhibited  


RCB0249   CKT-1   Very flat and thin kidney epithelial cell  


RCB0251   VA-13   SV40-transformed WI-38.  


RCB0252   W-V   SV40-transformed Werner's syndrome fibroblast  


RCB0256   BALL-1   Typical human B cell leukemia.  


RCB0266   CLA1RGB   Pseudo congenital lactic acidosis.  


RCB0270   KG-1-C   Glioma, S-100 Protein producing. Cell growth is slow.  


RCB0271   HeLa S3 (SC)   Suspension culturable. Useful for JIS medium inspection  


RCB0272   Vero-317   Culturable in proein-free MEM supplemented with biotin. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0273   BRL   ES cell differentiation inhibitory activity (DIA)  


RCB0275   SES-MaBr-1   Cabbage armyworm cell line applicable to large scale insect virus production.  


RCB0276   SES-MaBr-3   Cabbage armyworm cell line applicable to large scaale production of insect virus.  


RCB0278   NIAS-MB-25   Show finely branched cytoplasmic processes  


RCB0279   NIAS-MaBr-92   Susceptible to nuclear polyhedrosis virus  


RCB0282   NFSa Y83   In vivo transplantable highly metastatic sarcoma  


RCB0283   C-1300   Highly metastatic neuroblastoma  


RCB0284   Sq-1979   Metastatic epithelial cell  


RCB0285   CHO-K1   Widely used cell line, especially for biotechnol  


RCB0286   tk^(-)ts13   Thymidine kinase-defective mutant of ts13  


RCB0288   3Y1-B clone 1-6-2   Subclone of 3Y1-B clone 1.  


RCB0289   3Y1-B cl 1-6-K5-4-2   Subclone of 3Y1-B clone 1-6.  


RCB0290   3Y1-B clone 1   Mother clone of 3Y1 series  


RCB0291   3Y1ts-101   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0292   3Y1tsC102   Temperature-sensitive mutant of 3Y1, group C  


RCB0293   3Y1ts-103   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0294   3Y1ts-104   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0295   3Y1ts-105   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0296   3Y1tsA106   Temperature-sensitive mutant of 3Y1, group A  


RCB0297   3Y1tsB107   Temperature-sensitive mutant of 3Y1, group B  


RCB0298   3Y1ts-108   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0299   3Y1ts-109   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0301   3Y1ts-111   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0302   3Y1tsC112   Temperature-sensitive mutant of 3Y1, group C  


RCB0303   3Y1tsC113   Temperature-sensitive mutant of 3Y1, group C  


RCB0304   3Y1ts-114   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0305   3Y1ts-115   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0306   3Y1tsC116   Temperature-sensitive mutant of 3Y1, group C  


RCB0307   3Y1ts-117   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0308   3Y1ts-118   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0309   3Y1tsC119   Temperature-sensitive mutant of 3Y1, group C  


RCB0310   3Y1ts-120   Temearature-sensitive mutant of 3Y1 (see library).  


RCB0311   3Y1tsF121   Temperature-sensitive mutant of 3Y1, group F  


RCB0312   3Y1ts-122   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0313   3Y1tsD123   Temperature-sensitive mutant of 3Y1, group D  


RCB0314   3Y1tsD124   Temperature-sensitive mutant of 3Y1, group D  


RCB0315   3Y1tsG125   Temperature-sensitive mutant of 3Y1, group G  


RCB0316   3Y1tsF126   Temperature-sensitive mutant of 3Y1, group F  


RCB0317   3Y1ts-201   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0318   3Y1ts-202   Temperature-sensitive mutant of 3Y1 (see library).  


RCB0319   3Y1tsH203   Temperature-sensitive mutant of 3Y1, group H  


RCB0320   3Y1tsE204   Temperature-sensitive mutant of 3Y1, group E  


RCB0321   3Y1tsC205   Temperature-sensitive mutant of 3Y1, group C.  


RCB0322   3Y1tsD206   Temperature-sensitive mutant of 3Y1, group D  


RCB0323   3Y1-SB-15   Tetraploid clone of 3Y1  


RCB0324   3Y1-SB-16   Tetraploid clone of 3Y1  


RCB0325   3Y1BU^(r-1)   Thymidine kinase-defective mutant of 3Y1  


RCB0326   3Y1BU^(r-2)   Thymidine kinase-defective mutant of 3Y1  


RCB0327   3Y1BU^(r-3)   Thymidine kinase-defective mutant of 3Y1  


RCB0328   Ad12-3Y1-Z11   3Y1 transformed with adenovirus type 12  


RCB0329   Ad12-3Y1-Z13   3Y1 transformed with adenovirus type 12  


RCB0330   Ad12-3Y1-Z19   3Y1 transformed with adenovirus type 12  


RCB0331   Ad12-3Y1-W5   3Y1 transformed with adenovirus type 12  


RCB0332   E1A-3Y1-1   3Y1 transformed with adenovirus type 12 E1A gene  


RCB0333   E1A-3Y1-2   3Y1 transformed with adenovirus type 12 E1A gene.  


RCB0334   E1A-3Y1-3   3Y1 transformed with adenovirus type 12 E1A gene.  


RCB0335   in203-3Y1-7   3Y1 transformed with adenovirus in203.  


RCB0336   in203-3Y1-19   3Y1 transformed with adenovirus in203.  


RCB0337   in203-3Y1-23   3Y1 transformed with adenovirus in203.  


RCB0338   Ad2-3Y1-1   3Y1 transformed with adenovirus type 2  


RCB0339   Ad2-3Y1-2   3Y1 transformed with adenovirus type 2.  


RCB0340   Ad2-3Y1-3   3Y1 transformed with adenovirus type 2.  


RCB0343   SV-3Y1-C66   3Y1 transformed with SV40 virion.  


RCB0344   A640-3Y1-1   3Y1 transformed with SV40 tsA640  


RCB0347   dl-884-3Y1-KO1   3Y1 transformed with SV40 dl-884  


RCB0350   Py-3Y1-S2   3Y1 transformed with mouse polyoma virus  


RCB0353   SR-3Y1-1   3Y1 transformed with Rous sarcoma virus  


RCB0354   SR-3Y1-2   3Y1 transformed with Rous sarcoma virus  


RCB0356   HR-3Y1-1   3Y1 transformed with v-Ha-ras oncogene  


RCB0357   HR-3Y1-2   3Y1 transformed with v-Ha-ras oncogene  


RCB0359   NG-3Y1-D303   3Y1 transformed with nitrosoguanidine  


RCB0371   NG-3Y1-T18D   3Y1 transformed with nitrosoguanidine  


RCB0379   mos-3Y1-10   3Y1 transformed with v-mos oncogene  


RCB0380   mos-3Y1-16   3Y1 transformed with v-mos oncogene  


RCB0381   V12S-3Y1-2   3Y1 transformed with adenovirus type 12 12S-E1A  


RCB0384   V13S-3Y1-4   3Y1 transformed with adenovirus type 12 13S-E1A  


RCB0388   NCU-F1   Ehlers-Danlos syndrome  


RCB0389   NCU-F2   Morquio syndrome  


RCB0390   NCU-F3   Wilson's disease  


RCB0391   NCU-F4   Wilson's disease  


RCB0393   NCU-F6   Citrullinemia  


RCB0394   NCU-F7   Citrullinemia  


RCB0395   NCU-F8   Wilson's disease  


RCB0397   NCU-F10   Cockayne's syndrome  


RCB0402   HeLa·P3   Protein- & lipid-free medium growing  


RCB0403   CHO-K1 (SC)   CHO-K1 maintained in suspension culture.  


RCB0404   SES-MaBr-4   Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.  


RCB0405   NIAS-LeSe-11   Susceptible to insect viruses.  


RCB0407   WS2TKB   Werner's syndrome  


RCB0409   WS1TKB   Werner's syndrome, the same patient as RCB0433 WS1TKB2.  


RCB0410   MEN1RGB   Fibroblasts from multiple endocrine neoplasia  


RCB0411   HaP-T1   Mucin producing, BHP-induced pancreatic tumor  


RCB0412   NIAS-PX-64   Pupal ovary hemocyte.  


RCB0413   NIAS-MB-32   Show finely branched cytoplasmic processes. Application consideration  


RCB0414   NIAS-MaBr-93   larval hemocyte  


RCB0417   KU-1   Bovine B cell leukemia without virus production  


RCB0418   KU-17   Bovine leukemia virus producing. Surface Ig (+). Application consideration  


RCB0420   BHK-21C13-2P   Culturable in suspension, cf. ECACC ( BHK-21C13-3P).  


RCB0421   MEN2RGB   Fibroblasts from multiple endocrine neoplasia  


RCB0423   BL312   Bovine derived lymphocyte.  


RCB0426   SK-N-SH   Neuroblastoma, a target in CTL *****  


RCB0428   Saos-2   Osteogenic sarcoma  


RCB0429   SES-MaBr-5   Larval fat body hemocyte.  


RCB0431   T24   Bladder transitional-cell carcinoma  


RCB0432   MT-5   MNNG-initiated clone of BALB/3T3 clone A31  


RCB0433   WS1TKB2   Werner's syndrome, the same patient as RCB0409 WS1TKB.  


RCB0434   J774.1   Macrophage-like cell  


RCB0435   U-937 DE-4   Cloned U-937, differentiate with TNF  


RCB0436   HUC-F2   Normal umbilical card fibroblast, female  


RCB0437   HUC-Fm2   Normal umbilical cord fibroblast, male  


RCB0438   LC-1/sq-SF   Lung Cancer-1/squamous (RCB0455 LC-1/sq), serum-free cultured. Application consideration  


RCB0439   LC-1F   Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.  


RCB0440   LC-2/ad   Adenocarcinoma, moderately differentiated. Cell growth is slow. Application consideration  


RCB0441   SCCKN   Highly sensitive to bleomycin  


RCB0443   TC-YIK   Integrating HPV16, neurosecretory granules(+)  


RCB0444   RERF-LC-AI   Japanese lung squamous carcinoma.  


RCB0447   ARLJ301-3   Diploid rat liver epithelial cell line  


RCB0448   ARLJ301-3TR1   Spontaneous transformant of ARLJ301-3  


RCB0449   Anr4   EJ-ras oncogene transformed ARLJ301-3  


RCB0450   Anr9-1   EJ-ras oncogene transformed ARLJ301-3  


RCB0451   Anr13-1   EJ-ras oncogene transformed ARLJ301-3  


RCB0452   HTC/C3   Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin  


RCB0453   SHOK   Contact-inhibited hamster embryonal cell line  


RCB0455   LC-1/sq   Lung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F. Cell growth is slow.  


RCB0456   JTC-12   Cynomolgus monkey cell line.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0457   BM-N   Useful for recombinant BmNPV expression. Application consideration  


RCB0466   Lu-134-A   Small cell carcinoma, classic type. See Lu-134-B. Application consideration  


RCB0467   Lu-134-B   Small cell carcinoma, classic type. See Lu-134-A. Application consideration  


RCB0468   Lu-135   Small cell carcinoma, variant type. Application consideration  


RCB0469   Lu-139   Small cell carcinoma, classic type. Application consideration  


RCB0470   Lu-140   Small cell carcimoma, classic type. Application consideration  


RCB0471   CYNOM-K1   Cynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0473   DD762   Mammary tumor cell line without C-type virus  


RCB0474   K562/MTX-2   Methotrexate(MTX)-resistant K562 cell line  


RCB0475   ILT-Mat   IL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).  


RCB0476   Had-1   Newcastle disease virus resistant  


RCB0477   NB9   Neuroblastoma ( Another name : CHP-212, PMID: 6871857 ) . N-myc gene amplification. Application consideration  


RCB0478   NB16   Neuroblastoma. N-myc gene amplification.  


RCB0480   NB69   Neuroblastoma. N-myc gene unamplified tumor. Cell growth is slow. Application consideration  


RCB0481   TNB1   Neuroblastoma ( Another name : TGW, PMID: 2335222 ). N-myc gene amplification. Application consideration  


RCB0482   MC-NB-1   Neuroblastoma. N-myc gene amplicon analysis. Application consideration  


RCB0483   LA-N-1   Neuroblastoma. N-myc gene amplification.  


RCB0484   LA-N-2   Neuroblastoma. N-myc gene amplification.  


RCB0485   LA-N-5   Neuroblastoma. N-myc gene amplification.  


RCB0486   CHP-126   Neuroblastoma. N-myc gene amplification. Cell growth is slow. Application consideration  


RCB0487   CHP-134   Neuroblastoma. N-myc gene amplification. Application consideration  


RCB0488   3Y1-B clone 1-6   Standard clone of 3Y1 series. So called 3Y1  


RCB0489   NEC8   Embryonal carcinoma, testis.  


RCB0490   NEC14   Embryonal carcinoma, testis. Application consideration  


RCB0492   OTCD1TKB   OTC(-), X-linked, dominant (XD)  


RCB0494   NEC15   Embryonal carcinoma, testis. Application consideration  


RCB0495   KU812   Chronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.  


RCB0496   KU812E   Chronic myelogenous leukemia , subclone of RCB0495 KU812.  


RCB0497   KU812F   Chronic myelogeneous leukemia, subclone of RCB0495 KU812.  


RCB0500   HGC-27   Gastric cancer undifferentiated, mucin producing  


RCB0503   HeLa.S3(Mer^(-))   Repair deficient (mer~)  


RCB0504   MR1-3   MNNG-reistant HeLa.S3(Mer~) cells  


RCB0505   MR6   MNNG-resistant HeLa.S3(Mer~) cells  


RCB0507   MR10-1   MNNG-resistant HeLa.S3(Mer~) cells  


RCB0508   H-EMC-SS   Extraskeletal myxoid chondrosarcoma  


RCB0510   ACL-15   Metastasis to liver, lung  


RCB0511   RCN-9   Metastasis to liver, lung  


RCB0512   RCN-H-4   Metastasis to liver  


RCB0513   SKN   Estradiol-17 beta responsive leiomyosarcoma  


RCB0515   HSKTC   Krukenberg tumor cell line  


RCB0520   WR216   APRT(-) EB transformed B cell line  


RCB0521   HFL-I   Normal embryonic lung fibroblast  


RCB0522   HFL-II   Normal embryonic lung fibroblast  


RCB0523   HFL-III   Normal embryonic lung fibroblast  


RCB0524   HFL-AE-I   Human lung fibroblasts derived from anencephalous embryo.  


RCB0525   HFL-AE-II   Human lung fibroblasts derived from anencephalous embryo.  


RCB0526   Jyg-MC(A)   murine mammary tumor cell lines. High level MMTV producer line.  


RCB0527   Jyg-MC(B)   Murine mammary tumor cell lines. .Higher incidence in lung metastasis.  


RCB0528   MtT/S   Estrogen-induced tumor. Growth hormone producing. Application consideration.  


RCB0529   MtT/Se   Estradiol-dependent pituitary tumor. Application consideration.  


RCB0530   MtT/SM   Growth hormone, prolactin producing. Application consideration.  


RCB0531   TtT/M-87   Macrophage-like tumor dependent on L929 conditioned medium. Conditioned medium.  


RCB0533   Y1   Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.  


RCB0534   PK15   Buck-up culture of ECA86103005. Pig kidney, susceptible to hog cholea, foot & mouth disease.  


RCB0535   RAW 264   Buck-up culture of ECA8510291 . Mouse leukemic monocyte. Abelson leukemia virus induced. Application consideration  


RCB0536   STO   Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.  


RCB0537   JM   Buck-up culture of ECA86010201. . Human T cell line with the ability to grow HIV, the same patient as Jurkat.  


RCB0538   PU5-18   Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501 .  


RCB0539   COS-7   SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0540   HAL-01   Acute lymphatic leukemia  


RCB0544   MBT-2   Murine transitional cell carcinoma induced by FANFT  


RCB0545   OHTA   Mouse embryonic carcinoma  


RCB0546   AT-PDH1TKB   Pyruvate dehydrogenase deficiency fibroblasts.  


RCB0548   IA-5   Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic *****.  


RCB0549   Cle-H3   NIH3T3 transformant expressing human activated k-ras-2.  


RCB0550   Cle-H3^(neo+)   pSV2neo-introduced G418-resistant Cle-H3 mutant.  


RCB0554   IA-LM   Japanese lung large cell carcinoma  


RCB0555   GCIY   Stomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.  


RCB0556   NIAS-PX-58   Pupal ovary hemocyte.  


RCB0557   B16 melanoma 4A5   Melanin pigment producing mouse melanoma. Application consideration  


RCB0558   LLC   Highly metastatic and drug-resistant mouse tumor. Application consideration  


RCB0559   K-1.fl   SFFV producing Friend leukemia cell line. Non-differentiating.  


RCB0560   F5-5.fl   Friend leukemia. Differentiate to erythroblastoid cells with benzidine etc.  


RCB0561   T-3-Cl-2-0.fl   Friend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl  


RCB0562   TSFAT-3.fl   Friend leukemia. Differentiate to erythroblastoid cells.  


RCB0565   ATDC5   Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.  


RCB0566   CGM1   EB transformed B cell line  


RCB0568   ULF-23   Cold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).  


RCB0569   707.fl   Friend leukemia cell line. High ability to differentiate to erythroblastoid cells.  


RCB0570   GM86.fl   Friend leukemia cell line from DBA/2 mouse.  


RCB0571   FVTCT.fl   Friend leukemia cell line from BALB/c mouse. Virusnon-producing.  


RCB0580   SF8402   Control from a nonexposed individual with breast cancer, different specimen from RCB0635  


RCB0582   SF8404   Control from a nonexposed individual without cancer  


RCB0583   SF8405   Control from a nonexposed individual without cancer.  


RCB0584   SF8406   Control from a nonexposed individual without cancer.  


RCB0585   SF8657   Control from a nonexposed individual with stomach cancer  


RCB0587   SF8759   Atomic bomb survivor with breast cancer  


RCB0588   SF8760   Atomic bomb survivor with breast cancer.  


RCB0589   SF8761   Control from a nonexposed individual without cancer.  


RCB0590   SF8762   Atomic bomb survivor with breast cancer.  


RCB0591   HNS1A   Salamander cell line with large chromosomes. Cell growth is slow.  


RCB0592   HNS2   Larger epithelial cells than HNS1A.  


RCB0593   HNS3   Salamander cell line. Fibroblast-like cells.  


RCB0594   HNS4   Salamander cell line. Epithelial-like cells.  


RCB0595   HNS5   Salamander cell line. Fibroblast-like cells. Cell growth is slow.  


RCB0596   SF8758   Atomic bomb survivor with breast cancer  


RCB0597   SF8656   Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.  


RCB0598   SF8655   Atomic bomb survivor without cancer.  


RCB0600   SF8653   Atomic bomb survivor without breast cancer but with thyroid cancer.  


RCB0602   SF8650   Atomic bomb survivor with breast cancer  


RCB0603   SF8649   Atomic bomb survivor with breast cancer  


RCB0604   SF8647   Atomic bomb survivor with breast cancer.  


RCB0605   SF8546   Control from a nonexposed individual without cancer.  


RCB0608   SF8543   Control from a nonexposed individual with breast cancer  


RCB0610   SF8541   Control from a nonexposed individual with uterus cancer  


RCB0614   SF8536   Atomic bomb survivor without cancer  


RCB0617   SF8433   Atomic bomb survivor with breast cancer  


RCB0620   SF8429   Atomic bomb survivor with breast cancer  


RCB0621   SF8428   Atomic bomb survivor with breast cancer, different specimen from RCB0624  


RCB0624   SF8425   Atomic bomb survivor with breast cancer, different specimen from RCB0621.  


RCB0631   SF8416   Atomic bomb survivor with breast cancer  


RCB0633   SF8414   Control from a nonexposed individual with breast cancer  


RCB0634   SF8413   Control from a nonexposed individual with chest cancer  


RCB0635   SF8410   Control from a nonexposed individual with breast cancer, different specimen from RCB0580.  


RCB0637   CTLL-2   Cytotoxic T-cell line. IL-2 dependent.  


RCB0638   TCS   Keratinizing cervix squamous carcinoma, CEA(+)  


RCB0641   EoL-1 cell   Eosinophilic leukemia. Differenciate by n-butylate treatment.  


RCB0644   D134   MoAb IgM to sea urchin sperm dynein alpha-heavy chain.  


RCB0646   D264   MoAb IgM to sea urchin sperm dynein beta-heavy chain.  


RCB0648   D308   MoAb IgM to sea urchin sperm dynein beta-heavy chain.  


RCB0649   D52   MoAb IgM to sea urchin sperm dynein IC1.  


RCB0650   D9   MoAb IgM to sea urchin sperm dynein IC2.  


RCB0651   D58   MoAb IgG1 to sea urchin sperm dynein IC2.  


RCB0654   D16   MoAb IgG1 to sea urchin sperm dynein IC3.  


RCB0657   HOKUG   Glassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.  


RCB0658   HHUA   Expressing receptor to estrogen and progesterone. Cell growth is slow.  


RCB0659   HOUA-I   Poorly differentiated adenocarcinoma. Cell growth is slow.  


RCB0660   HTMMT   Mixed Mullerian tumor.  


RCB0662   HOTHC   Thyroid tumor. TAF, G-CSF, colloid producing.  


RCB0665   HFWT   Wilms' tumor. CA125 and TPA producing.  


RCB0666   HSNB   N-myc propagated. Neuron specific enolase producing.Application consideration  


RCB0669   PCH42-63   Hybridoma against differentiated PC-12 cell surface  


RCB0673   PCH41-43   Hybridoma against differentiated PC-12 cell surface  


RCB0674   PCH41-44   Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.  


RCB0676   PCH42-58   Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.  


RCB0678   PCH54-37   Hybridoma against differentiated PC-12 cell surface  


RCB0679   HDC   Mother of a Down's syndrome child. 46XX,t(2/q2/q)  


RCB0680   HKBMM   Human malignant meningioma.  


RCB0684   HFL-AE-III   Human lung fibroblasts derived from anencephalous embryo.  


RCB0685   SKG-II-SF   Large cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.  


RCB0687   KP-N-NS   Adrenal neuroblastoma derived from brain metastasis  


RCB0688   QG-U   Japanese cervix carcinoma.  


RCB0689   TCO-2   Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).  


RCB0690   HOTHC-SF   Serum-free, protein-free cultured HOTHC cells  


RCB0697   GM2-1TKB   Tay-Sachs' disease  


RCB0698   HFSKF-II   Normal human fetal skin fibroblast.  


RCB0700   HTMM   Malignant melanoma from lympho node.  


RCB0701   143B/TK^(-)neo^(R)   v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.  


RCB0702   WI-38   The most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.  


RCB0704   WI-38   The most famous normal human fibroblast. Obtained directly from L. Hayflick.  


RCB0705   10H   Anti poly(ADP-ribose) IgG3 kappa producing.  


RCB0706   Verots S3(SF)   Expressing SV40 tsA58 large T antigen. Verots S3 cultured in protein-free MEM. G418-resistant.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0707   Verots S3   Expressing SV40 tsA58 large T antigen. Possible to culture in protein-free MEM. G418-resistant.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0708   HF10B4   Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.  


RCB0709   HyLDH·YK-1   Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.  


RCB0710   HyLDH·YK-2   Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium  


RCB0711   HyGPD·YK-1-1   Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.  


RCB0713   HTUD1   Large cells with large chromosomes.  


RCB0715   CHAUT-G   Smooth muscle cell sarcoma from Chinese hamster.  


RCB0721   GOTO·P3   Subline of GOTO. Protein-free medium adapted. Cell growth is slow.  


RCB0725   MS-1   Small lung carcinoma. PTHrP producing.  


RCB0733   NLS-6-5   Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.  


RCB0735   OS-RC-2   Renal tumor cell from a Japanese. Transplantable to nude mice.  


RCB0736   DJM-1   Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.  


RCB0738   MTHC-1   Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.  


RCB0739   MTHC-2   Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.  


RCB0740   MTHC-3   Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.  


RCB0748   Mm1   Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.  


RCB0749   MFH-ino   Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.  


RCB0750   TLR2   Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.  


RCB0752   TKD2   Kidney epithelial cells containing temperature sensitive SV40 large T antigen. Compared to TKC2.  


RCB0753   OMC-1   Japanese cervix squamous cell carcinoma. Once said TA-4 positive.  


RCB0755   OMC-3   Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.  


RCB0760   MT-8   Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.  


RCB0761   505-05-01   Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.  


RCB0762   MT-9   Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.  


RCB0763   GI-1   Human glioma separated from gliosarcoma.  


RCB0764   Fvp^(r)B350   Topoisomerase II inhibitor VP-16 resistant FM3A mutant.  


RCB0768   HP50-2   Hydrogen peroxide resistant HL60-derived clone.  


RCB0769   HP100-1   Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.  


RCB0770   XTY   Frog (Xenopus laevis) cell line derived from subcutaneous tumor.  


RCB0771   XTC-YF   Frog (Xenopus laevis) cell line derived from tadpole.  


RCB0772   A6   Frog (Xenopus laevis) cell line derived from kidney.  


RCB0773   A8   Frog (Xenopus laevis) cell line derived from liver.  


RCB0774   EC-GI-10   Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.  


RCB0775   F-36P   GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.  


RCB0776   F-36E   Subline of F-36P. Erythropoietin-dependent  


RCB0777   HMV-II   Melanin producing. Originated from the same site of HMV-I.  


RCB0778   CW-2   Colon carcinoma. CEA-positive, nude mouse-transplantable.  


RCB0782   RC4   Normal rabbit cornea cells. Usually transform spontaneously during serial culture.  


RCB0783   FCP-S1M   Skin fibroblasts from a familial colon polyposis patient.  


RCB0784   FCP-S2H   Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  


RCB0785   FCP-S3H   Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  


RCB0786   FCP-S4H   Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  


RCB0787   FCP-S5H   Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  


RCB0788   FCP-S6H   Skin fibroblasts from a familial colon polyposis patient at Hiroshima.  


RCB0789   HSQ-89   Japanese maxillary simus squamous carcinoma  


RCB0792   T88-M   IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell  


RCB0793   B151K12   IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.  


RCB0794   2C6   Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.  


RCB0795   1B2C6   Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.  


RCB0796   1C3D3   Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.  


RCB0797   1C3IKEI   Human embryonic pancreas-derived cell line. See RCB0794,0795,0796.  


RCB0803   NBsusSR   Isolated from a patient with hiper dopaminemia andnorepinephrinemia.  


RCB0804   BRF41   Zebrafish fin fibroblast. Cell growth is slow.  


RCB0805   Ba/F3   IL-3 dependent pro B cell line.??Conditioned medium.Information.  


RCB0806   Jurkat   Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.  


RCB0808   MMAc   Human melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.  


RCB0819   HMMME   Human malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.  


RCB0820   HKBML   Human brain derived lymphoma. Epstein-Barr virus positive.  


RCB0844   8C9   Producing anti-human CD36 MoAb.  


RCB0867   3-2H3   Anti-human-myeloperoxidase MoAb producing.  


RCB0868   4-2C11   Anti-human-myeloperoxidase MoAb producing.  


RCB0869   9-1A11   Anti-human-myeloperoxidase MoAb producing.  


RCB0870   12-1B6   Anti-human-myeloperoxidase MoAb producing.  


RCB0871   LLC-GA5-CoL150   Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.  


RCB0872   LLC-GA5-CoL300   Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.  


RCB0875   Chab1KMM   Chromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.  


RCB0876   RGM1   So called clear cells from rat stomach mucosa.  


RCB0881   OCUB-M   Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.  


RCB0882   OCUB-F   Same as OCUB-1, OCUB-M. Chromosome = pseudodiploid  


RCB0959   HH13-1   Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.  


RCB0960   HH17-4   Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.  


RCB0966   HGRT   Benign mature tridermal teratoma.  


RCB0967   HTST   Human sacrococcygeal teratoma.  


RCB0978   HIRS-BM   Mixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.  


RCB0980   Sa3   Squamous carcinoma cells derived from human oral cancer.  


RCB0982   ECC4   Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.  


RCB0983   ECC10   Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.  


RCB0985   Ae   Worm cell line established by Grace. Culturable in MGM-450-10%FBS.  


RCB0987   C2C12   Said differentiate to myotubes, but need confirmation. Backup of ECA91031101 .  


RCB0988   CACO-2   Human colon carcinoma. Backup of ECA86010202 . Application consideration  


RCB0989   COLO 679   Melanoma from a 47 year old female. Backup of ECA87061210 .  


RCB0990   CPAE   Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401 .  


RCB0991   G-361   Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401 .  


RCB0992   HOS   Sensitive to further transformation with both virus and chemicals. Backup of ECA87070202 .  


RCB0993   IEC 6   Rat small intestine epithelial cells. Backup of ECA88071401 .  


RCB0994   MA104   Highly susceptible to Simian rotavirus SA11. Backup of ECA8510291 .??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB0995   MDCK   Canine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903 .  


RCB0996   Mv.1.Lu(NBL-7)   Aleutian mink cells. Used for focus forming *****s for murine and ferine sarcoma viruses.Back up culture of ECA88050503 .  


RCB0998   117-13   Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell  


RCB0999   MKN7   c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.  


RCB1001   MKN45   Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.  


RCB1002   MKN74   Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.  


RCB1003   MKN1   Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.  


RCB1005   KP4   Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.  


RCB1006   KP4-1   Pancreatic ductal cell carcinoma. PTHrP producing.  


RCB1007   KP4-2   Pancreatic ductal cell carcinoma. PTHrP producing.  


RCB1008   KP4-3   Pancreatic ductal cell carcinoma. PTHrP producing.  


RCB1009   ECC12   Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. Application consideration  


RCB1010   HOEF   Endometrium-derived fibroblasts.  


RCB1011   H-AE-IV   Anencephalous embryonic fibroblast.  


RCB1012   T3M-5   G-CSF producing thyroidal squamous carcinoma.  


RCB1015   T3M-1 Clone2   G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.  


RCB1017   T3M-1 Cl-10   G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.  


RCB1018   T3M-3   Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.  


RCB1020   T3M-10   Lung large cell carcinoma producing CSF. Cell growth is slow.  


RCB1021   T3M-4   Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.  


RCB1022   T3M-11   Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.  


RCB1024   IMR-90-SV   SV40 transformed human lung fibroblast.  


RCB1025   RTH33   SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.  


RCB1026   GM95   Glucosylceramide synthetase-deficient B16 melanoma mutant.  


RCB1027   MEB4   Not expressing melanoma antigen. Control for GM-95 cell line.  


RCB1032   NOS-1   Osteoid producing in vitro and in nude mice. Cell growth is slow.  


RCB1033   NOS-2   Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.  


RCB1034   CJM   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1035   CJM Cl4   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1036   CJM Cl5   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1037   CJM Cl6   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1038   CJM Cl7   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1039   CJM Cl8   Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  


RCB1062   LMSU   Human cell line derived from lymph node metastasis of gastric cancer.  


RCB1088   ψCRIP-P131   High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.  


RCB1089   ψCRIP-MFGmGM-CSF   Producer of MoMLV-derived retrovirus including mouse GM-CSF cDNA  


RCB1090   ψCRIP-MFGmIL-1α   High-titer producer of MoMLV-derived retrovirus including mouse IL-1alpha cDNA.  


RCB1091   ψCRIP-MFGmIL-1RA   High-titer producer of MoMLV-derived retrovirus including mouse IL-1 receptor antagonist cDNA  


RCB1092   ψCRIP-MFGmIL-2   High-titer producer of MoMLV-derived retrovirus including mouse IL-2 cDNA  


RCB1093   ψCRIP-MFGmIL-3   Producer of MoMLV-derived retrovirus including mouse IL-3 cDNA  


RCB1094   ψCRIP-MFGmIL-4   Producer of MoMLV-derived retrovirus including mouse IL-4 cDNA  


RCB1095   ψCRIP-MFGmIL-6   Producer of MoMLV-derived retrovirus including mouse IL-6 cDNA  


RCB1096   ψCRIP-MFGmIL-7   Producer of MoMLV-derived retrovirus including mouse IL-7 cDNA  


RCB1097   ψCRIP-MFGmIL-10   Producer of MoMLV-derived retrovirus including mouse IL-10 cDNA  


RCB1098   ψCRIP-MFGmIL-12p40   Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p40 subunit. Refer RCB1099.  


RCB1099   ψCRIP-MFGmIL-12p35   Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p35 subunit. Refer RCB1098.  


RCB1100   ψCRIP-MFGmTNF-α   Producer of MoMLV-derived retrovirus including mouse TNF-alpha gene.  


RCB1101   ψCRIP-MFGhTNF-α   Producer of MoMLV-derived retrovirus including human TNF-alpha cDNA.  


RCB1102   ψCRIP-MFGmLT   Producer of MoMLV-derived retrovirus including mouse lymphotoxin cDNA.  


RCB1103   ψCRIP-MFGmG-CSF   Producer of MoMLV-derived retrovirus including mouse G-CSF gene.  


RCB1104   ψCRIP-MFGhM-CSF   Producer of MoMLV-derived retrovirus including human M-CSF gene.  


RCB1105   ψCRIP-MFGmIFN-γ   High-titer producer of MoMLV-derived retrovirus including mouse IFN-gamma cDNA.  


RCB1106   ψCRIP-MFGhMIF   Producer of MoMLV-derived retrovirus including human MIF cDNA.  


RCB1107   ψCRIP-MFGmLIF   Producer of MoMLV-derived retrovirus including mouse leukemia inhibitory factor cDNA.  


RCB1108   ψCRIP-MFGmkitLigand   Producer of MoMLV-derived retrovirus including mouse kit ligand (SCF) cDNA.  


RCB1109   ψCRIP-MFGhOncost-M   Producer of MoMLV-derived retrovirus including human oncostatin M cDNA.  


RCB1110   ψCRIP-MFGmB7   Producer of MoMLV-derived retrovirus including mouse B7 (CD80) cDNA.  


RCB1111   ψCRIP-MFGmB7-2   Producer of MoMLV-derived retrovirus including mouse B7-2 (CD86) cDNA.  


RCB1112   ψCRIP-MFGtrγIFNR   Producer of MoMLV-derived retrovirus including the trancated form of mouse IFN-gamma cDNA.  


RCB1113   ψCRIP-MFGrab-IL1RA   Producer of MoMLV-derived retrovirus including rabbit IL-1 receptor antagonist cDNA.  


RCB1114   ψCRIP-MFGratGM-CSF   Producer of MoMLV-derived retrovirus including rat GM-CSF cDNA.  


RCB1115   ψCRIP-MFGneo   Producer of MoMLV-derived retrovirus including neo gene.  


RCB1116   ψCRIP-MFGHSVtk   Producer of MoMLV-derived retrovirus including HSV thymidine kinase cDNA.  


RCB1117   ψCRE-MFGts-c-src   Producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.  


RCB1118   ψCRIP-MFGts-c-src   High-titer producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.  


RCB1119   ψCRE-MFGtsT   High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.  


RCB1120   ψCRIP-MFGtsT   High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.  


RCB1124   OP9   Support hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.  


RCB1125   TOM-2   Glassy cell carcinoma from cervix. Cell growth is slow.  


RCB1126   MC3T3-E1   Differentiate to osteoblasts. Collagen producing.  


RCB1127   MC3T3-G2/PA6   Support hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.  


RCB1129   TGBC1TKB   Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration  


RCB1130   TGBC2TKB   Japanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration  


RCB1139   HFSKF-AE-V   Human skin fibroblasts from embryo.  


RCB1142   10H-2   Anti poly(ADP-ribose) IgG3 kappa producing.  


RCB1143   DA-1   IL-3 dependent mouse myeloid cells. MoLV induced.  


RCB1144   DA-3   IL-3 dependent mouse myeloid cells. MoLV induced.  


RCB1145   32D   IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.  


RCB1148   TGBC11TKB   Japanese gastric cancer, lymph node metastated. Application consideration  


RCB1151   RCC10RGB   Kidney carcinoma from a Japanese patient. Cell growth is slow.  


RCB1152   Sawano   Naturally raised CDDP(cisplatin)-resistant cell line.  


RCB1153   S2 (Drosophila)   Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1.  


RCB1154   KGN   Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.  


RCB1155   Hepa-E1   Eel hepatocyte. Application consideration  


RCB1157   UV-P3U1-B8   Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.  


RCB1158   B16F10/mGM   Mouse GM-CSF producing B16 melanoma.  


RCB1164   MOLT-3   Human T cell leukemia, the same patient as RCB0206 MOLT-4.  


RCB1165   YAC-1   Natural killer cell-sensitive mouse lymphoma.  


RCB1166   KG-1   Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+  


RCB1167   P-815   Mouse mastocytoma. Used as a target cells for cytotoxic T cell *****s.  


RCB1168   SKW-3   Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979  


RCB1169   TGBC18TKB   Papillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow. Application consideration  


RCB1171   HOUFXXX   47,XX,+X-type chromosome.  


RCB1174   GEM-81   Tumor cells derived from Gold Fish red pigment cells.  


RCB1175   GEM-199   Tumor cells derived from Gold Fish red pigment cells.  


RCB1176   GEM-218   Tumor cells derived from Gold Fish red pigment cells.  


RCB1178   HuG1-PI   Stomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.  


RCB1179   HuG1-N   Stomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.  


RCB1180   Tanoue   B-lineage acute lymphoblastic leukemia.  


RCB1181   ST   A subclone of RCB1180 Tanoue.  


RCB1182   GR-ST   RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.  


RCB1184   Lu-165   Producing high level of anti-diuretic hormone. Application consideration  


RCB1185   TT1TKB   Rectal carcinoma from a Japanese patient. Cell growth is slow. Application consideration  


RCB1186   TGBC14TKB   Japanese gallbladder tumor passed through a nude mouse. Application consideration  


RCB1187   TUHR3TKB   Japanese kidney carcinoma cells. RCB original. Cell growth is slow.  


RCB1188   NRS-1   Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration  


RCB1189   THP-1   Differentates to macrophage-like cells after treatment with phorbol ester. The variant subline (RCB2128 A-THP-1). Application consideration  


RCB1190   7-TD-1   Responding to IL-6 in the bio*****.  


RCB1191   5637   Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.  


RCB1192   MDA-MB-453   Human breast carcinoma established from an effusion. Application consideration  


RCB1193   COLO-320   Described to produce serotonin, epinephrine.  


RCB1196   TGBC24TKB   Japanese gallbladder carcinoma established from metastated ascite. Application consideration  


RCB1197   P2UR/K-562   Expressing P2U receptor acting in signal transduction pathway.  


RCB1198   TUHR4TKB   Japanese renal carcinoma cells. Cell growth is slow.  


RCB1200   MMAc·SF   Serum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit  


RCB1205   Anti-PT-S1-1B7   Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.  


RCB1208   Anti-PT-S1-10D6   Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  


RCB1209   Anti-PT-S1-8G4   Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  


RCB1212   Anti-PT-S1-3F10   Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  


RCB1214   Anti-PT-S1-4D10   Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.  


RCB1215   Anti-PT-S23-11E6   Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.  


RCB1220   Anti-PT-S2-3A12   Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.  


RCB1222   Anti-PT-S2-9G8   Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.  


RCB1223   Anti-PT-S3-7E10   Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.  


RCB1229   Anti-PT-S4-7F2   Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.  


RCB1233   Anti-PT-S4-1H2   Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.  


RCB1238   Anti-FHA(2)2E9   Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.  


RCB1239   Anti-FHA(1)1C6   Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.  


RCB1240   Anti-α(1)1C6F4   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1243   Anti-α(4)11D9G5   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1244   Anti-α(5)11D10B6   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1246   Anti-α(7)7C9A10   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1247   Anti-α(8)9F3A6   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1248   Anti-α(9)12G8B11   MoAb to Clostridium perfringens alpha-toxin (phospholipase C).  


RCB1250   Anti-θ(1)3H10   MoAb to Clostridium perfringens theta-toxin.  


RCB1264   tsBN2   Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.  


RCB1267   tsBN7   Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.  


RCB1268   tsBN462   Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration  


RCB1269   tsBN75   Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.  


RCB1270   tsBN51   Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.  


RCB1271   tsBN67   Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.  


RCB1272   tsBN250   Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.  


RCB1273   tsBN269   Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.  


RCB1275   TUHR10TKB   Japanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.  


RCB1278   MtT/E   Estrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se. Application consideration.  


RCB1279   TtT/GF   Pituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.  


RCB1280   TGBC50TKB   3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration  


RCB1281   TGBC51TKB   3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration  


RCB1282   TGBC52TKB   3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration  


RCB1283   B16 melanoma   Mouse melanoma producing melanin. Application consideration  


RCB1284   B16 melanoma/lacZ   Mouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.  


RCB1285   3A21   Anti-ribonuclease A antibody producing.  


RCB1286   ECPC-3   Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.  


RCB1287   ECPC-4   Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape  


RCB1290   OIH-1   Human myeloid leukemia cell line with chromosome 18 trisomy and mutation in DCC gene. Cell growth is slow. Application consideration  


RCB1294   HRC-17   Hybridoma producing anti-E antigen of the human Rh blood group system  


RCB1296   HNT-34   AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. Application consideration  


RCB1297   HYT-1   Human acute myeloid leukemia derived cell.  


RCB1303   anti-αA-crystallin   Anti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1304   anti-αB-crystallin   Anti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1305   anti-β5-crystallin   Anti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1306   anti-β6-crystallin   Anti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1307   anti-γ1-crystallin   Anti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1308   anti-δ-crystallin   Anti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.  


RCB1311   C3H/HeN-emb   Mouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.  


RCB1312   C57BL/6J-emb   Mouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.  


RCB1313   RERF-LC-KJ   Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.  


RCB1316   CTB-1   Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.  


RCB1317   KU-SN   Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.  


RCB1366   HuH-7   Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.  


RCB1367   HuH-6   Hepatoblastoma. Said albumin and alpha-fetoprotein producing.  


RCB1369   NBT-T1   A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.  


RCB1370   NBT-T2   A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.  


RCB1371   NBT-L1   A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.  


RCB1372   NBT-L2a   A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.  


RCB1373   NBT-L2b   A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.  


RCB1374   1-8   CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1375   2-2   35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1376   2-7   A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1377   32Dcl3   Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.  


RCB1378   MuSS   A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.  


RCB1382   CF1TKB   Japanese cystic fibrosis fibroblast.  


RCB1383   TUHR14TKB   Japanese renal carcinoma cells. Cell growth is slow.  


RCB1422   L929   TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.  


RCB1423   BHK-21   The parent cell line used for the temperature sensitive cell line series of BN.  


RCB1425   LCAM1   Human lung cancer derived cell.  


RCB1426   PMF-ko14   Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.  


RCB1429   SN-512   Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.  


RCB1433   TEN   So called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).  


RCB1434   KE-39   Human cell line derived from gastric cancer  


RCB1435   KE-97   Human cell line derived from intraperitoneal metastasis of gastric cancer  


RCB1437   AW-EBV-LCL   B95-8 EB virus transformed leukemia cell line.  


RCB1438   TW-EBV-LCL   B95-8 EB virus transformed (originally normal) B cell line.  


RCB1440   ATN-1   Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).  


RCB1444   MBHL-2   Insect cell line derived from Mamestra brassicae. Cell growth is slow.  


RCB1445   MBHL-3   Insect cell line derived from Mamestra brassicae  


RCB1449   C7   p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene. Cell growth is slow.  


RCB1450   LM8   A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).  


RCB1451   L929   Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.  


RCB1456   RCR-1   Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.  


RCB1460   PCM6   Human myeloma cell.  


RCB1461   JTC-15   Subclone of AH-66, lost transplantability in rats. Possible to culture in DMEM medium. See RCB0063.  


RCB1464   DT40   Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.  


RCB1465   SHIP^(-) DT40   SHIP deficient DT40 cells  


RCB1466   SHP1^(-) DT40   SHP1 deficient DT40 cells  


RCB1467   IP3R^(-) DT40   IP3R(type1,type2,type3) deficient DT40 cells  


RCB1468   Btk^(-) DT40   Btk deficient DT40 cells  


RCB1469   PLC-γ2^(-) DT40   PLC-γ2 deficient DT40 cells  


RCB1470   Syk^(-) DT40   Syk deficient DT40 cells  


RCB1471   Lyn^(-) DT40   Lyn deficient DT40 cells  


RCB1472   M   Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.  


RCB1473   LYM-1   Sticky cell from lymph node. Possible to culture in DMEM medium.  


RCB1474   RLC-16   Epithelial cell from rat liver. Possible to culture in DMEM medium.  


RCB1477   CHO-RD   Subline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration  


RCB1479   JTC-27   Ascites hepatoma. Possible to culture in DMEM medium. See RCB0065.  


RCB1483   OV2944-HM-1   Lymphnode-metastatic ovarian tumor. So called HM-1 cells.  


RCB1484   RLC-18   Non tumorigenic in nude mice. Possible to culture in DMEM medium.  


RCB1485   JTC-12   Cynomolgus monkey cell line. Possible to culture in DMEM medium. See RCB0456.??¥?¥·¥ó¥è¥ó?òìó?D?Y?£  


RCB1486   JTC-19   Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .  


RCB1487   MY-EBV-LCL   B95-8 EB virus transformed (originally normal) B cell line.  


RCB1489   RLC-27   Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.  


RCB1495   FU-RPNT-1   Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration  


RCB1498   Grap^(-) DT40   Grap deficient DT40 cells  


RCB1499   Grb2^(-) DT40   Grb2 deficient DT40 cells  


RCB1500   Lyn^(-)/Syk^(-) DT40   Lyn and Sky deficient DT40 cells  


RCB1501   SHP1^(-)/SHP2^(-) DT40   SHP1 and SHP2 deficient DT40 cells  


RCB1502   SHP2^(-) DT40   SHP2 deficient DT40 cells  


RCB1503   Shc^(-) DT40   Shc deficient DT40 cells  


RCB1506   clone YP1N25   Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible. Cell growth is slow.  


RCB1507   clone YP1N27   A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.  


RCB1508   clone 76   Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.  


RCB1509   clone 64   Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.  


RCB1510   BLNK^(-) DT40   BLNK deficient DT40 cells  


RCB1512   MH7A   Rheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.  


RCB1513   HOMM   Melanoma cells with melanin-granules. Cell growth is slow.  


RCB1514   HOCE   Japanese choriocarcinoma cell line. Cell growth is slow. Application consideration  


RCB1517   A-6(ES derived)   Mouse ES (RCB1778 H-1) cell derived cell, useful for study of hematopoiesis.  


RCB1518   SS-A3-1   F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.  


RCB1520   JHOC-5   Clear cell adenocarcinoma. Said CA125, CA72-4 producing. Application consideration  


RCB1521   JHOS-2   Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. Application consideration  


RCB1525   HeLa.S3   = RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.  


RCB1528   CCP-2   Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  


RCB1530   CCP-7   Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  


RCB1531   CCP-8   Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  


RCB1534   MLC-1-B   Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  


RCB1535   MLC-2-4   Bone marrow stroma cell line, depositing calcified matrix on the culture surface.  


RCB1536   MLC-6   Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.  


RCB1537   MLC-7   Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  


RCB1538   32Dcl3   Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.  


RCB1539   P19.CL6   Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.  


RCB1541   HFL9t   47, +del(9)(q12) chromosome, the same patient as RCB1542.  


RCB1542   HFSK9t   47, +del(9)(q12) chromosome, the same patient as RCB1541.  


RCB1543   JHTKI-col-L   B lymphocytes isolated from a colon adenocarcinoma.  


RCB1544   JHUAS-1   Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow. Application consideration  


RCB1545   JHUAS-2-L   B lymphocyte isolated from Japanese adenosquamous carcinoma.  


RCB1546   JHOS-3   Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. Application consideration  


RCB1547   JHUCS-1   Japanese uterine carcinosarcoma. Nude mouse transplantable. Application consideration  


RCB1548   JHUEM-1   Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing. Application consideration  


RCB1549   YSCCC   Human cell line derived from cholangiocellular carcinoma. Cell growth is slow.  


RCB1550   HL-60-R2   Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.  


RCB1551   JHUEM-2   Japanese endometrioid adenocarcinoma. Application consideration  


RCB1552   JHUEM-3   Human uterus endometrioid adenocarcinoma cell line. Application consideration  


RCB1555   F9   Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.  


RCB1556   RF/6A 135   Spont. transformant from choroid retina. Only slightly reactive to Factor VIII. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1558   JHUS-nk1   Human uterus squamous cell carcinoma cell line. Application consideration  


RCB1560   PWS-Yamaguchi   Prader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.  


RCB1561   RML-Yoshi   Severe insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.  


RCB1564   ψCRIP-RxnZ   Subline of ψCRIP that produce virus to express LacZ possessing nuclear localization signal.  


RCB1572   ψCRIP-hBax-i-hCD25-CS   Retrovirus producer. Produce virus to express human Bax protein.  


RCB1573   ψCRIP-ATR-bsr   Cell line producing retrovirus to express angiotensin receptor.  


RCB1574   ψCRIP-RxhCD82   Cell line producing retrovirus to express the human CD82.  


RCB1575   ψCRIP-Rx-crmA-bsr   Cell line producing retrovirus to express the anti-apoptotic crmA.  


RCB1576   ψCRIP-Rx-ETBR-bsr   Cell line producing retrovirus to express the human endothelin receptor.  


RCB1577   ψCRIP-mPCNF1-bsr   Cell line producing retrovirus to express the mouse calcineurin.  


RCB1579   ψCRIP-MFG-Z   Cell line producing retrovirus to express lac Z.  


RCB1580   ψCRIP-MFG-T37   Cell line producing retrovirus to express SV40 large T antigen.  


RCB1581   ψCRIP-MSHR   Cell line producing retrovirus to express human MSH receptor.  


RCB1582   ψCRIP-NCre   Cell line producing retrovirus to express Cre recombinase.  


RCB1583   ψCRIP-hp53-bsr   Cell line producing retrovirus to express human p53 and blasticidin S deaminase gene.  


RCB1584   ψCRIP-RxBcl-XL-i-bsr   Cell line producing retrovirus to express human Bcl-xL and blasticidin S deaminase gene.  


RCB1585   ψCRIP-RxhFAS-i-CD80   Cell line producing retrovirus to express human FAS and human CD80.  


RCB1587   ψCRIP-RxhSecR-bsr   Cell line producing retrovirus to express human secretin receptor and blasticidin S deaminase gene.  


RCB1588   ψCRIP-hSSR-bsr   Cell line producing retrovirus to express human somatostatin receptor and blasticidin S deaminase gene.  


RCB1589   ψCRIP-RxmPCNT1-i-bsr   Cell line producing retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase gene.  


RCB1590   ψCRIP-RxhVIPR-bsr   Cell line producing retrovirus to express human VIP receptor and blasticidin S deaminase gene.  


RCB1591   SRA 01/04   alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.  


RCB1593   OS3   ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes  


RCB1597   KKC   Mouse T cell line transformed by Gross leukemia virus.  


RCB1598   NCKA   Mouse T cell line transformed by Gross leukemia virus.  


RCB1600   KKF   Mouse T cell line transformed by Gross leukemia virus.  


RCB1601   KKB   Mouse T cell line transformed by Gross leukemia virus.  


RCB1604   DHA3-1   Mouse T cell hybridoma expressing double HA-tag alone.  


RCB1605   DHA3-26   Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  


RCB1606   DMyc3-45   Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .  


RCB1607   DHA9-3   Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  


RCB1608   DHA9-13   Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  


RCB1609   DHA9-15   Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  


RCB1610   DMyc9-36   Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  


RCB1611   M4   Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.  


RCB1613   HFL-AE-VI   Human lung fibroblasts derived from anencephalous embryo.  


RCB1615   HFSKF-AE-VII   Human skin fibroblasts derived from anencephalous embryo. RCB1617 and RCB1618 are derived from the same embryo.  


RCB1617   HFL-AE-VII   Human lung fibroblasts derived from anencephalous embryo. RCB1615 and RCB1618 are derived from the same embryo.  


RCB1618   HFLI-AE-VII   Human liver fibroblasts derived from anencephalous embryo. RCB1615 and RCB1617 are derived from the same embryo.  


RCB1620   ΔDNAPK-DT40   DNA PK gene deleted DT40 (chicken B cell line).  


RCB1621   ΔKu70-DT40   Ku70 gene deleted DT40 (chicken B cell line).  


RCB1622   ΔRad51B-DT40   Rad51B gene deleted DT40 (chicken B cell line).  


RCB1623   ΔRad51C-DT40   Rad51C gene deleted DT40 (chicken B cell line).  


RCB1624   ΔRad51D-DT40   Rad51D gene deleted DT40 (chicken B cell line).  


RCB1625   ΔXRCC2-DT40   XRCC2 gene deleted DT40 (chicken B cell line).  


RCB1626   ΔXRCC3-DT40   XRCC3 gene deleted DT40 (chicken B cell line).  


RCB1627   ΔRad52-DT40   Rad52 gene deleted DT40 (chicken B cell line).  


RCB1628   ΔRad54-DT40   Rad54 gene deleted DT40 (chicken B cell line).  


RCB1629   ΔMre11-DT40(#190)   Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.  


RCB1630   ΔMre11-DT40(#194)   Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.  


RCB1631   ΔRad51+hRad51-DT40   Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).  


RCB1632   ΔKu70ΔRad54B-DT40   Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).  


RCB1633   ΔMre11ΔKu70-DT40   Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).  


RCB1634   ΔRad54ΔRad54B-DT40   Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).  


RCB1635   K-562   Human CML derived cell line. Deposited directly from the institution that has established this cell.  


RCB1637   293   Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.  


RCB1638   Hepa 1-6   Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.  


RCB1639   LoVo   CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.  


RCB1640   DAUDI   Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.  


RCB1641   EL4   9,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.  


RCB1642   3T3 Swiss Albino   Contact inhibition. Buck up culture of ECA2854.  


RCB1644   BeWo   It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.  


RCB1645   Y79   Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.  


RCB1647   RAJI   Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.  


RCB1648   Hep G2   hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870. Almost equal to RCB0459, but the restriction is a. Information  


RCB1649   ΔAtm-DT40   ATM gene deleted DT40 (chicken B cells).  


RCB1650   ΔAtmΔKu70-DT40   ATM and Ku70 gene double-deleted DT40 (chicken B cells).  


RCB1651   ΔAtmΔRad54+hRad54-DT40   ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.  


RCB1652   G1MF285D   Hybridoma that produce anti-human G1MF (allotype of IgG1) antibody.  


RCB1668   293/CrmA   293 cell line expressing the caspase-inhibiting CrmA gene  


RCB1672   ΔRad54+hRad54-DT40   Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.  


RCB1675   Cbl^(-) DT40   Cbl deficient DT40 cells  


RCB1676   JHOM-1   Human ovary mucinous adenocarcinoma cell line. Application consideration  


RCB1677   JHUEM-7   Human uterus endometrial adenocarcinoma cell line. Application consideration  


RCB1678   JHOS-4   Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. Application consideration  


RCB1680   TUHR25TKB   Human cell line derived from kidney cancer.  


RCB1681   GS-HepG2   A subline of HepG2. Expressing abundant glutamine synthetase. Information  


RCB1682   JHOM-2B   Human ovary mucinous tubular adenocarcinoma cell line. Application consideration  


RCB1687   ΔRad54ΔKu70-DT40   Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).  


RCB1688   JHOC-7   Human ovary clear cell carcinoma cell line. Application consideration  


RCB1690   CPN4B   Cell line derived from embryo of Cynops pyrrhogaster. Cell growth is slow.  


RCB1691   Tpit/F1   Folicular dendritic cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.  


RCB1692   Tpit/E   Immature pituitary cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse. PMID: 24881870  


RCB1695   RMS-YM   Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.  


RCB1696   SPB-1   Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.  


RCB1697   SPB-1/cLCB1   SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.  


RCB1698   LY-B   Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.  


RCB1699   LY-B/cLCB1   LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.  


RCB1701   MY   Human cell line derived from p180-BCR-ABL dependent leukemia.  


RCB1702   SLVL   Human cell line derived from splenic B cell lymphoma.  


RCB1704   BLNK^(-)/Syk^(-) DT40   BLNK and Syk deficient DT40 cells  


RCB1705   JHCA-ov   Human colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Application consideration  


RCB1706   JHCOLOYI   Human cell line derived from rectal cancer. Application consideration  


RCB1708   JHTSK-col-L   Human B cell-like cell line derived from colon adenocarcinoma tisuue.  


RCB1709   GE1   Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration  


RCB1716   BCAP^(-) DT40   BCAP deficient DT40 cells  


RCB1717   IP3R type1^(-)/2^(-) DT40   IP3R type1 and IP3R type2 deficient DT40 cells  


RCB1718   IP3R type1^(-)/3^(-) DT40   IP3R type1 and IP3R type3 deficient DT40 cells  


RCB1719   IP3R type2^(-)/3^(-) DT40   IP3R type2and IP3R type3 deficient DT40  


RCB1721   JHUCS-3   Human cervical cancer cell line. Application consideration  


RCB1723   JHOC-8   Human ovary clear cell carcinoma cell line. Application consideration  


RCB1724   JHSK-rec   Human rectal cancer cell line. Application consideration  


RCB1728   Hpr-4   H2O2 resistant Chinese Hamster V79 cells  


RCB1731   TM-31   Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)  


RCB1741   NHOS   Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.  


RCB1747   ΔNBS1-DT40   Subline of DT40 (chicken B cell line), lacking Nbs1 expression.  


RCB1749   ΔDinB-DT40   Subline of DT40 cell line, lacking DinB expression.  


RCB1750   ΔRad18-DT40   Subline of DT40 cell line, lacking Rad18 expression.  


RCB1752   BS-SHI-4M   Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.  


RCB1753   KMY-J   Meningioma derived cell line. Derived from rat F344.  


RCB1754   KMY-1   Subline of KMY-J. Fibroblast-like  


RCB1755   KMY-2   Subline of KMY-J. Epithelial-like  


RCB1756   KMY-3   Subline of KMY-J. Polyploidy  


RCB1757   HS-P   Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.  


RCB1759   ΔDNAPKΔKu70-DT40   Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.  


RCB1764   ΔRev3-DT40   Subline of DT40 cell line, lacking Rev3 expression.  


RCB1766   ΔligIV-DT40   Subline of DT40 cell line, lacking ligase IV expression.  


RCB1767   ΔRad52ΔXRCC3-DT40   Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.  


RCB1768   ΔXRCC3-cond1-DT40   Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.  


RCB1769   ΔXRCC3-cond2-DT40   Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.  


RCB1770   XRCC3+/--DT40   Subline of DT40 cell line, lacking XRCC3 only in one allele.  


RCB1771   Lu-24   Human cell line derived from lung cancer. Oat cell type. Application consideration  


RCB1772   Lu-141   Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  


RCB1773   Lu-143   Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  


RCB1785   Lu-138   Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  


RCB1788   AT805   Mouse teratoma-derived cell line. Parent cell line of ATDC5.  


RCB1790   P19C6   Embryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.  


RCB1791   PCC3/A/1   Mouse teratoma-derived cell line.  


RCB1792   SIL-6/1   Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.  


RCB1794   ΔRad18ΔXPA-DT40   Subline of DT40 cell line, lacking both of Rad18 and XPA expression.  


RCB1795   ΔRad18ΔDinB-DT40   Subline of DT40 cell line, lacking both of Rad18 and DinB expression.  


RCB1797   BP7(R80)   Rat renal tumor derived cell line.  


RCB1798   BP11(R2)   Rat (Wistar) cell line derived from renal (kidney) tumor.  


RCB1799   BP11(R100)   Rat (Wistar) cell line derived from renal (kidney) tumor.  


RCB1800   BP13(R2)   Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  


RCB1801   BP13(R100)   Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  


RCB1802   BP26(R2)   Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  


RCB1803   BP26(R80)   Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.  


RCB1804   BP30(R2)   Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  


RCB1805   BP30(R100)   Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  


RCB1806   BP36B(R2)   Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  


RCB1807   BP36B(R100)   Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  


RCB1809   Vav3^(-) DT40   Vav3 deficient DT40 cells  


RCB1810   PI3Kp110α^(-) DT40   PI3Kp110α deficient DT40 cells  


RCB1811   ΔBLM-DT40   Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.  


RCB1812   ΔWRN-DT40   Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.  


RCB1813   ΔWRNΔBLM-DT40   Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.  


RCB1814   ΔDinBΔXPA-DT40   Subline of DT40 cell line, lacking both of DinB and XPA expression.  


RCB1817   DT40(v-myb^+)WT   A subline of avian cell line, DT40, expressing v-myb exogenously.  


RCB1818   DT40(v-myb^+)Δpolβ   A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.  


RCB1819   DT40(v-myb^+)Δpolλ   A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.  


RCB1820   DT40(v-myb^+)Δpolβλ   A subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.  


RCB1821   CHO-FLAG-hBLT1   Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).  


RCB1822   CHO-HA-hBLT2   Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).  


RCB1823   CHO·1F8   Subline of CHO-K1 that expresses human platelet activating factor receptor.  


RCB1824   TRP1^(-) DT40   TRP1 deficient DT40  


RCB1829   SC-1   Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.  


RCB1830   Rat-1   Rat fibroblast-like cell line that can be transformed by oncogenes.  


RCB1831   XC   Cell line for titration of murine leukemia virus.  


RCB1832   THK   SV40 transformed hamster cell line. Fibroblast-like cells.  


RCB1833   Mink   Lung epithelial cell line derived from mink. Useful for focus forming *****s for murine leukemia virus.  


RCB1834   S+L-Mink   Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.  


RCB1835   Sirc   Fibroblast-like cell line derived from rabbit.  


RCB1836   Grb2^(-)/Grap^(-) DT40   Grb2and Grap deficient DT40 cells  


RCB1837   MVP1   Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  


RCB1838   MVP25   Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  


RCB1839   MVP47   Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  


RCB1840   MVP49   Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  


RCB1841   MVP51   Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.  


RCB1845   ΔUbc9+cUbc9-DT40   Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously  


RCB1846   HSC-F   T cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1847   ES-8040 20-2   Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  


RCB1848   ES-8047 2-1   Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  


RCB1849   C-8049   Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  


RCB1850   C-8052   Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  


RCB1851   DT40 Cre1   A subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).  


RCB1853   MSH6-1-[ClX3.16]DT40   A subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).  


RCB1854   HSP-239   T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1855   HSP-250   T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1856   TX-7F (hybridoma)   Hybridoma producing a monoclonal antibody against tetrodotoxin.  


RCB1857   DA-3 (hybridoma)   Hybridoma producing a monoclonal antibody against domoic acid.  


RCB1858   GT-13A (hybridoma)   Hybridoma producing a monoclonal antibody against gonyautoxin.  


RCB1859   MDBK-NST   Bovine kidney-derived epithelial cell line. FBS independent for culture.  


RCB1860   BLNK^(-)Grb2^(-)DT40   BLNK and Grb2 deficient DT40 cells  


RCB1861   T-23   Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB1862   NIH3T3-3-4   Subclone of NIH3T3  


RCB1863   GRP1^(-)DT40   Ras GRP1 deficient DT40 cells  


RCB1864   GRP3^(-)DT40   Subline of DT40 cell line, lacking RasGRP3 expression.  


RCB1865   GRP1^(-)/GRP3^(-)DT40   Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.  


RCB1866   Sos1^(-)DT40   Subline of DT40 cell line, lacking Sos1 expression.  


RCB1867   Sos2^(-)DT40   Subline of DT40 cell line, lacking Sos2 expression.  


RCB1868   Sos1^(-)/Sos2^(-)DT40   Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.  


RCB1869   LY-A   Subline of CHO-K1 cell line in which trafficking of ceramide is deficient  


RCB1870   LY-A/hCERT   Subline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered  


RCB1871   TL-1   Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607 (Deposited from Tohoku Univ.). Application consideration  


RCB1872   A431   Human cell line derivd from epidermoid carcinoma.TKG0182 (Deposited from Tohoku Univ.).  


RCB1873   JTK-LCL   Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).  


RCB1874   KOIA-LCL   EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC¢aTAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).  


RCB1875   XPL 5   Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).  


RCB1876   211-LCL-MUC1   Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs.TKG0615 (Deposited from Tohoku Univ.).  


RCB1878   RPMI1788   IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).  


RCB1879   PEER   Human T cell line derived from acute T cell leukemia.TKG0377 (Deposited from Tohoku Univ.).  


RCB1881   TL-Mor   Human derived T cell line. HTLV-1 pro-virus DNA(+).TKG0369 (Deposited from Tohoku Univ.).  


RCB1882   BALL-1   Human cell line derived from B cell leukemia. TKG0467(Deposited from Tohoku Univ.).  


RCB1884   H-111-TC   Human cell line derived from gastric cancer. TKG0411(Deposited from Tohoku Univ.). Cell growth is slow.  


RCB1886   Hep G2   Human cell line derived from hepatocyte carcinoma.TKG0205 (Deposited from Tohoku Univ.). Information  


RCB1889   HEp-2   Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).  


RCB1890   MG-63   Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).  


RCB1891   HeLa TG   A subline of HeLa. 6-thioguanine resistant. TKG0204(Deposited from Tohoku Univ.).  


RCB1892   SKG-IIIa   Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462 (Deposited from Tohoku Univ.).  


RCB1894   TE-1   Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).  


RCB1896   TN-2   Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).  


RCB1897   K562   Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes. TKG0210(Deposited from Tohoku Univ.).  


RCB1898   K562/Adr   Subline of K562. Resistant to adriamycin. TKG0211(Deposited from Tohoku Univ.).  


RCB1900   Lu99   Lung giant cell carcinoma cell line derived from human.TKG0495 (Deposited from Tohoku Univ.).  


RCB1901   PK-59   Human cell line derived from pancreatic cancer. TKG0492(Deposited from Tohoku Univ.).  


RCB1902   HSC-4   Human tongue squamous cell carcinoma derived cell line.TKG0489 (Deposited from Tohoku Univ.).  


RCB1903   OVK18   Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).  


RCB1904   MCF7   Human cell line derived from breast adenocarcinoma.TKG0479 (Deposited from Tohoku Univ.).  


RCB1905   Sq-1   Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration  


RCB1907   TKKK   Human cell line derived from intrahepatic bile duct cancer.TKG0456 (Deposited from Tohoku Univ.).  


RCB1909   8305C   Human thyroid anaplastic carcinoma derived cell line.TKG0446 (Deposited from Tohoku Univ.).  


RCB1911   CCD-IC   Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.  


RCB1912   CNT   Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.  


RCB1913   PST-S2   Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.  


RCB1914   BBWV-22K3-9B   Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  


RCB1915   BBWV-22K5-12A   Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  


RCB1916   BBWV-22K6-2A   Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.  


RCB1918   J#176-3.2   Hybridoma producing a monoclonal antibody against mouse JDP2.  


RCB1919   J#214.2-2   Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.  


RCB1920   J#249.1-1   Hybridoma producing a monoclonal antibody against mouse JDP2.  


RCB1921   NRG   Mouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.  


RCB1922   1C7   Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  


RCB1923   13D10   Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  


RCB1924   h1c   Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.  


RCB1925   WA-mFib   Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.  


RCB1926   OT11   RBP-J deficient mouse fibroblasts  


RCB1927   OT13   Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)  


RCB1928   KG-1a   Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402(Deposited from Tohoku Univ.).  


RCB1932   T2   Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).  


RCB1933   NALM-6   Human cell line derived from B cell leukemia. TKG0413(Deposited from Tohoku Univ.).  


RCB1934   HUT78   Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375 (Deposited from Tohoku Univ.).  


RCB1935   HPB-ALL   Human cell line derived from T cell leukemia. TKG0199(Deposited from Tohoku Univ.).  


RCB1936   MOLT-4F   Human T leukemic cell line (CD4+). CR2 receptor (+).TKG0229 (Deposited from Tohoku Univ.).  


RCB1938   P30/OHK   Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.).  


RCB1939   NUGC-4   Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).  


RCB1940   SH-10-TC   Human cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412(Deposited from Tohoku Univ.).  


RCB1941   Li-7   Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing. TKG0368 (Deposited from Tohoku Univ.).  


RCB1942   HuH-7   Human cell line derived from hepatoma. TKG0206(Deposited from Tohoku Univ.).  


RCB1943   HuH-28   Human cell line derived from cholangiocellular carcinoma.TKG0438 (Deposited from Tohoku Univ.).  


RCB1945   HSC-2   Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487(Deposited from Tohoku Univ.).  


RCB1947   Ca Ski   Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).  


RCB1949   TE-5   Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).  


RCB1950   TE-6   Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257(Deposited from Tohoku Univ.).  


RCB1951   TE-15   Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).  


RCB1952   SCCH-26   Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).  


RCB1953   NB-1   Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486 (Deposited from Tohoku Univ.).  


RCB1954   T98G   Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.).  


RCB1955   KMST-6   Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).  


RCB1960   HuCCT1   Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.).  


RCB1963   VMRC-RCW   Human renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).  


RCB1965   EBC-1   Human lung squamous cell carcinoma cell line. TKG0481(Deposited from Tohoku Univ.).  


RCB1966   S1   Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration  


RCB1967   LU65   Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).  


RCB1970   LK-2   Human lung squamous cell carcinoma cell line. TKG0494(Deposited from Tohoku Univ.).  


RCB1971   Lu99B   Human lung giant cell carcinoma cell line. TKG0496(Deposited from Tohoku Univ.).  


RCB1972   PK-1   Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239 (Deposited from Tohoku Univ.).  


RCB1973   PK-45H   Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).  


RCB1974   SAS   Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).  


RCB1975   HSC-3   Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).  


RCB1976   Ca9-22   Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485 (Deposited from Tohoku Univ.).  


RCB1980   CCRF-CEM   Human cell line derived from T cell leukemia. TKG0563(Deposited from Tohoku Univ.).  


RCB1981   HD-Mar2   Human cell line derived from Hodgkin's lymphoma.TKG0198 (Deposited from Tohoku Univ.).  


RCB1988   TE-9   Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse.TKG0260 (Deposited from Tohoku Univ.).  


RCB1990   KUSA-H1   Mouse bone marrow-derived stromal cells.  


RCB1991   KUSA-O   Mouse multipotent mesenchymal cells. Derived from bone marrow.  


RCB1992   UV♂1d   Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  


RCB1993   UV♀1A   Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  


RCB1994   UV♀2   Mouse vascular endothelial cell line. Transformed by ultraviolet.  


RCB1995   UV·BAL-1.1   Mouse skin derived cell line. Induced by ultra-violet irradiation.  


RCB1996   UV·BAL-2.1D   Mouse skin derived cell line. Induced by ultra-violet irradiation.  


RCB1997   UV·B6-1.1   Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  


RCB1998   UV·B6-2.1A   Mouse skin derived cell line. Induced by ultra-violet irradiation.  


RCB1999   UV·B6-4.1   Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.  


RCB2000   UV·B6-5.1   Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  


RCB2013   GMR3   Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).  


RCB2014   GMB7   Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).  


RCB2015   GMR8   Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).  


RCB2016   AMR19   Hybridoma producing a monoclonal antibody against ganglioside lactones.  


RCB2021   GGR41   Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.  


RCB2024   UV·BAL-3.3   Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)  


RCB2025   UV·BAL-5.4G   Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)  


RCB2026   UV·BAL-6.1E   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2027   UV·BAL-7.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2028   UV·BAL-8.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2029   UV·BAL-8.1C   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2030   UV·BAL-12.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2031   UV·BAL-13.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2032   UV·BAL-14.2   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2033   UV·BAL-15.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2034   UV·BAL-16.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2035   UV·BAL-17.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2036   UV·BAL-18.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2037   NGR54   Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.  


RCB2039   NMR52   Hybridoma producing a monoclonal antibody against nLc4Cer.  


RCB2040   NGR50   Hybridoma producing a monoclonal antibody against SGPG.  


RCB2041   AMR20   Hybridoma producing a monoclonal antibody against GalCer.  


RCB2042   AGB43   Hybridoma producing a monoclonal antibody against Sulfatide.  


RCB2046   BMR26   Hybridoma producing a monoclonal antibody against Globoside.  


RCB2048   OMB4   Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.  


RCB2049   OMR5   Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.  


RCB2050   OMR6   Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.  


RCB2053   UV·C3H-3.3   Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  


RCB2056   UV·C3H-8.2   Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  


RCB2057   UV·BAL-19.1A   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2058   UV·BAL-20.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2059   UV·BAL-21.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2060   UV·BAL-23.1   Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  


RCB2061   UV·C3B6-1.1   Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2062   UV·C3B6-1.1C   Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2065   UV?CB6-2.1F   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2066   UV·CB6-3.4B   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2067   UV?CB6-4.1D   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2068   UV?CB6-4.1F   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2070   UV·CB6-5.2   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2071   UV·CB6-5.2B   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2072   UV?CB6-6.1   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2073   UV?CB6-6.1B   Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  


RCB2074   UV·CC3-11.1   Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.  


RCB2076   Has   Chinese hamster cell line. Epithelial-like adherent cells.  


RCB2078   FU-RPNT-2   Human primitive neuroectodermal tumor cell line derived from kidney.  


RCB2081   KUSA-A1   Mesenchymal stem cell line derived from C3H/He mouse strain.  


RCB2082   103-LCL   Human B cell line transformed by Epstein-Barr Virus.TKG0614 (Deposited from Tohoku Univ.).  


RCB2083   141-LCL   Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.).  


RCB2084   TALL-1   Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).  


RCB2088   Kato III   Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).  


RCB2092   87-5   Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).  


RCB2093   II-18   Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).  


RCB2094   MIA Paca2   Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.).  


RCB2095   PANC-1   Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).  


RCB2097   TE-4   Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0255(Deposited from Tohoku Univ.).  


RCB2098   TE-8   Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma.TKG0259 (Deposited from Tohoku Univ.).  


RCB2099   TE-10   Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.).  


RCB2100   TE-11   Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma.TKG0262 (Deposited from Tohoku Univ.).  


RCB2101   TE-14   Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma.TKG0265 (Deposited from Tohoku Univ.).  


RCB2102   HO-1-u-1   Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).  


RCB2103   8505C   Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439(Deposited from Tohoku Univ.).  


RCB2104   HuO-3N1   Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.).  


RCB2105   D98-AH2   Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191(Deposited from Tohoku Univ.).  


RCB2106   ME-180   Human cell line derived from cervical cancer. TKG0437(Deposited from Tohoku Univ.).  


RCB2107   TN-1   Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).  


RCB2108   NH-12   Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.).  


RCB2109   NH-6   Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).  


RCB2110   YKG1   Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.).  


RCB2111   K562/Vin   Subline of K562 cell line. Resistant to vincristine. TKG0212(Deposited from Tohoku Univ.).  


RCB2112   KUM4   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2113   KUM6   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2114   KUM7   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2115   KUM9   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2116   TSt-4   Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.  


RCB2117   TSt-4/G   Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.  


RCB2118   TSt-4/G-DLL1   Original murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.  


RCB2119   TSt-4/N   Original murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.  


RCB2120   TSt-4/N-DLL1   Original murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.  


RCB2125   BmN4-DR   Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration  


RCB2126   BmN4-IR   Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration  


RCB2127   COLO205   Human cell line derived from colon cancer. Derived from ascites metastasis. Cell growth is slow. TKG0457 (Deposited from Tohoku Univ.).  


RCB2128   A-THP-1   Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296(Deposited from Tohoku Univ.).  


RCB2133   S2   Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration  


RCB2134   86-2   Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).  


RCB2135   NIH:OVCAR-3   Human cell line derived from adenocarcinoma of ovary.TKG0602 (Deposited from Tohoku Univ.).  


RCB2136   YST-1   Human cell line derived from schwannoma. TKG0454(Deposited from Tohoku Univ.).  


RCB2138   KLM-1   Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).  


RCB2141   PK-45P   Human cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient. TKG0493(Deposited from Tohoku Univ.).  


RCB2143   DU145   Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).  


RCB2144   LNCap.FGC   Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603 (Deposited from Tohoku Univ.).  


RCB2145   PC-3   Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).  


RCB2146   WERI-Rb-1   Human cell line derived from retinoblastoma. TKG0601(Deposited from Tohoku Univ.).  


RCB2147   KUM3   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2148   KOP   Mouse fibroblast-like cell line lacking p38 MAP kinase expression.  


RCB2149   RKOP   Subline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.  


RCB2150   EKOP   Subline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.  


RCB2151   ZKOP   Subline of KOP cell line. Zeocin-resistant.  


RCB2163   UE6E7-16   Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.  


RCB2202   293T   Human cell line expressing SV40 large T antigen abundantly.  


RCB2203   TFS-2   Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.  


RCB2204   TFS-4   Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.  


RCB2205   NCC-RbC-39   Human retinoblastoma cell line.  


RCB2206   NCC-RbC-51   Human retinoblastoma cell line derived from cervical lymph node metastasis.  


RCB2208   NCC-RbC-54   Human cell line derived from retinoblastoma.  


RCB2212   NCC-RbC-59   Human cell line derived from retinoblastoma. Cell growth is slow.  


RCB2213   NCC-RbC-60   Human cell line derived from retinoblastoma.  


RCB2214   NCC-RbC-67   Human cell line derived from retinoblastoma.  


RCB2217   NCC-RbC-83   Human cell line derived from retinoblastoma.  


RCB2218   NCC-RbC-92   Human cell line derived from retinoblastoma.  


RCB2219   NCC-RbC-T1   Human cell line derived from retinoblastoma.  


RCB2223   NCC-OvC-K119   Human cell line derived from ovarian cancer.  


RCB2224   NCC-StC-K140   Human cell line derived from stomach cancer.  


RCB2225   JHUEM-14   Human cell line derived from uterus cancer. Endometrioid adenocarcinoma. Application consideration  


RCB2226   JHOC-9   Human cell line derived from ovary cancer. Clear cell carcinoma. Application consideration  


RCB2227   JMSU1   Human cell line derived from urinary bladder carcinoma. Derived from ascites.  


RCB2229   HS-Os-1   Human cell line derived from osteosarcoma.  


RCB2230   HS-Sch-2   Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).  


RCB2231   HS-SY-II   Human cell line derived from synovial sarcoma. Application consideration  


RCB2233   HE12   Human fibroblast-like cells derived from embryo. Not immortalized. Application consideration  


RCB2234   HE13   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2237   HE16   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2238   HE18   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2239   HE19   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2240   HE21   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2241   HE22   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2244   HE27   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2245   HE28   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2246   HE29   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2247   HE30   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2248   HE31   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2249   HE32   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2250   HE33   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2251   HE34   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2253   HKb20   Subline of HEK293 cell line, expressing BtR175b (Cry 1Aa receptor).  


RCB2254   HE36   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2256   HE37   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2257   HE38   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2258   HE39   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2259   HE40   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2260   HE41   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2261   HE42   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2262   HE46   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2263   HE47   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2264   HE48   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2265   HE49   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2266   HE50   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2267   HE51   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2268   HE52   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2269   HE53   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2270   HE54   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2271   HE55   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2273   HE57   Human fibroblast-like cells derived from embryo. Not immortalized.  


RCB2277   GSS   Human gastric cancer cell line derived from metastasis at liver.  


RCB2278   GSU   Human cell line derived from gastric cancer. Established from the cells in ascites.  


RCB2279   WA-hT   Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.  


RCB2280   HCE-T   SV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium.  


RCB2281   T3M-12   Human lung small cell carcinoma cell line. ADH producing.  


RCB2282   701-LCL   Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610 (Deposited from Tohoku Univ.).  


RCB2283   277-LCL   Human B cells transformed by Epstein-Barr virus. TKG0609(Deposited from Tohoku Univ.).  


RCB2286   XPL 17   Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311(Deposited from Tohoku Univ.).  


RCB2287   XPL 20   Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313(Deposited from Tohoku Univ.).  


RCB2288   211-LCL   Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616 (Deposited from Tohoku Univ.).  


RCB2292   ACC-MESO-1   Human malignant pleural mesothelioma cell line.  


RCB2293   ACC-MESO-4   Human malignant pleural mesothelioma cell line.  


RCB2295   KUM10   Mouse mesenchymal cell line derived from bone marrow.??C57/B6.  


RCB2296   CARMA1^(-)DT40   Subline of DT40 cell line, lacking CARMA1 expression.  


RCB2297   PKCβ^(-)DT40   Subline of DT40 cell line, lacking PKC-β expression.  


RCB2298   TAK1^(-)DT40   Subline of DT40 cell line, lacking TAK1 expression.  


RCB2299   RMC-1   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2300   RMC-2   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2301   RMC-3   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2302   RMC-6   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2303   RMC-11   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2304   RMC-17   Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  


RCB2305   MIH5(GIT)   Hybridoma producing a monoclonal antibody against mouse B7-H1.  


RCB2306   PC3.1   Hybridoma producing monoclonal antibody against latexin.  


RCB2307   T1.7   Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.  


RCB2308   802C11   Hybridoma producing monoclonal antibody against MuSc.  


RCB2309   JFP-J1   Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  


RCB2310   JFP-J5   Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  


RCB2311   JFP-K2   Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.  


RCB2312   859H5   Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.  


RCB2313   884F11   Hybridoma producing monoclonal antibody against mouse apolipoprotein E.  


RCB2314   F9/LM10   Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.  


RCB2315   F9/LM(1+10)   Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.  


RCB2316   AB1   Hybridoma producing monoclonal antibody against GD1b gangliosides.  


RCB2317   AC1   Hybridoma producing monoclonal antibody against GD1c gangliosides.  


RCB2318   P19.CL6   Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.  


RCB2319   LACF-NaNaI   Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB2320   LACF-NaNaII   Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  


RCB2322   KUM5   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2323   9-15C   Mouse mesenchymal cell line derived from bone marrow.??C3H/He  


RCB2324   MIH5(RPMI)   Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.  


RCB2326   CHO-AA8   A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation *****s at the APRT and HPRT loci.  


RCB2327   EM-9   A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.  


RCB2328   irs1SF   A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.  


RCB2329   V-3   A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.  


RCB2330   CHO-K1   Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.  


RCB2331   XR-1   A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.  


RCB2332   V79-4   A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  


RCB2335   V-E5   X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.  


RCB2336   V-G8   A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.  


RCB2337   V79B   A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  


RCB2338   XR-V9B-4   A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  


RCB2339   XR-V15B   A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  


RCB2341   NCR-G1   Human cell line derived from embryonal carcinoma of testis.  


RCB2342   NCR-G2   Human cell line derived from embryonal carcinoma of testis.  


RCB2343   NCR-G3   Human cell line derived from embryonal carcinoma of testis.Application consideration  


RCB2344   NCR-G4   Human cell line derived from embryonal carcinoma of testis.  


RCB2345   EEB   Human cell line derived from erythroblastic leukemia.  


RCB2346   NMFH-1   Human cell line derived from myxofibrosarcoma.  


RCB2347   NMS-2   Human cell line derived from malignant peripheral nerve sheath tumor.  


RCB2348   NOS-10   Human cell line derived from osteosarcoma.  


RCB2351   OGU1   Human cell line derived from primary effusion lymphoma (PEL). Application consideration  


RCB2352   633   Human lung cancer cell line expressing capsid protein of human adenovirus.  


RCB2354   293gp   Retroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.  


RCB2355   HeLa CD4+Clone1022   A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.  


RCB2356   HeLa-CD4-LTR-β-gal   A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.  


RCB2358   HLtat   A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.  


RCB2360   HS-ES-2M   Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  


RCB2361   HS-ES-2R   Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  


RCB2362   HS-PSS   Human cell line derived from malignant peripheral nerve sheath tumor.  


RCB2364   HS-ES-1   Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.  


RCB2365   JHONA   Human cell line derived from ovarian squamous cell cancer.Application consideration  


RCB2367   KT01   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.  


RCB2368   KT02   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.  


RCB2369   KT03   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.  


RCB2372   KT06   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.  


RCB2375   KT09   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  


RCB2376   KT10   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  


RCB2377   KT11   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  


RCB2378   KT12   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.  


RCB2379   KT13   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.  


RCB2380   KT14   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.  


RCB2381   KT16   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  


RCB2382   KT17   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  


RCB2383   KT18   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.  


RCB2386   KT21   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.  


RCB2388   KT23   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.  


RCB2389   KT26   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.  


RCB2390   KT27   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.  


RCB2392   KT29   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.  


RCB2393   KT30   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.  


RCB2395   KT32   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.  


RCB2400   KT54   Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.  


RCB2402   STIM1^(-)DT40   Subline of DT40 cell line, lacking STIM1 expression.  


RCB2403   MG6   Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bio***** using SC-1 cells.  


RCB2530   A172   Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.).  


RCB2531   CB-3512   Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305 (Deposited from Tohoku Univ.).  


RCB2532   HuO 9N2 (O9N2)   Human cell line derived from osteosarcoma. TKG0451(Deposited from Tohoku Univ.).  


RCB2534   M-MOK   Human cell line derived from megakaryoblastic leukemia.TKG0458 (Deposited from Tohoku Univ.).  


RCB2535   OVK18#102   Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).  


RCB2536   T24   Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).  


RCB2537   TFK-1   Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).  


RCB2539   XPL 19   Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312(Deposited from Tohoku Univ.).  


RCB2540   XPL 24   Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus.TKG0314 (Deposited from Tohoku Univ.).  


RCB2541   141-LCL-MUC1   Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).  


RCB2610   FELV3281-AD   Cat cell line derived from lymphoma.  


RCB2611   MDCK-AD   Dog cell line derived from kidney.  


RCB2614   KLN205-MUC1   Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).  


RCB2618   BCL1-B20   Mouse cell line derived from B cell leukemia. TKG0435(Deposited from Tohoku Univ.).  


RCB2619   L929   Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).  


RCB2620   C-1300N18   Mouse cell line derived from neuroblastoma. TKG0307(Deposited from Tohoku Univ.). Application consideration  


RCB2621   M1(D+)   Mouse cell line derived from meyloid leukemia. TKG0319(Deposited from Tohoku Univ.).  


RCB2623   KLN205   Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).  


RCB2627   BOY-12E   Human cell line derived from urinary bladder carcinoma.TKG0641 (Deposited from Tohoku Univ.).  


RCB2630   B16 F10   Mouse cell line derived from melanoma. TKG0348(Deposited from Tohoku Univ.).  


RCB2633   MM46 CEA1-2   Mouse cell line derived from mammary carcinoma.TKG0597 (Deposited from Tohoku Univ.).  


RCB2634   MM46-APR-MUC1 cl.1   Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously.TKG0595 (Deposited from Tohoku Univ.).  


RCB2637   A4   Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).  


RCB2638   B16/BL6   Mouse cell line derived from melanoma.?? TKG0598(Deposited from Tohoku Univ.).  


RCB2639   NB2a   Mouse cell line derived from neuroblastoma. TKG0509(Deposited from Tohoku Univ.).  


RCB2640   G-415   Human cell line derived from gallbladder carcinoma.TKG0642 (Deposited from Tohoku Univ.).  


RCB2642   MUSS   Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497 (Deposited from Tohoku Univ.).  


RCB2643   F9   Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration  


RCB2648   D4   A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). Cell growth is slow. TKG0300 (Deposited from Tohoku Univ.).  


RCB2649   B16 F1   Mouse cell line derived from melanoma. C57BL/6J strain.TKG0347 (Deposited from Tohoku Univ.).  


RCB2651   JLS-V9   Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).  


RCB2652   J774-1   Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).  


RCB2657   Colon-26   Mouse cell line derived from colon cancer. BALB/c strain.TKG0518 (Deposited from Tohoku Univ.).  


RCB2660   MEDEP-E14   Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.  


RCB2686   JTC-35   Bovine granulosa cell line.  


RCB2691   MEDEP-E14 clone 4   A subclone of MEDEP-E14(RCB2660) following cloning procedure.  


RCB2692   MEDEP-BRC4-1   Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.  


RCB2693   MEDMC-NT2   Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.  


RCB2694   MEDMC-BRC6   Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.  


RCB2695   RD-C2   Mouse osteoblast-like cell line derived from Runx2 deficient mouse.  


RCB2696   RD-C6   Mouse osteoblast-like cell line derived from Runx2 deficient mouse.  


RCB2700   PK-8   Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).  


RCB2709   2F8   Hybridoma producing monoclonal antibody against oxitocin receptor.  


RCB2710   Atg5^(+/+)MEF   Mouse embryonic fibroblasts. Wild type control for RCB2711.  


RCB2711   Atg5^(-/-)MEF   Mouse embryonic fibroblasts lacking Atg5 gene expression.  


RCB2712   MAEC   Mouse cell line derived from aorta of p53-deficient mouse. Epithelial like.  


RCB2718   MT-7   Rat cell line derived from fibrous histiocytoma. After cloning.  


RCB2719   MT-10   Rat cell line derived from fibrous histiocytoma. After cloning.  


RCB2720   MT-R8   A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  


RCB2721   MT-R9   A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  


RCB2722   MT-10R   A subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  


RCB2723   MT-PR   A subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. The parent cell line, MT-P, is also deposited but not available yet.  


RCB2724   KB-D8   Rat cell line derived from dendritic cell carcinoma in thymus.  


RCB2725   KJ-A   Rat cell line derived from malignant fibrous histiocytoma.  


RCB2726   KE-F11   Rat cell line derived from malignant schwannoma.  


RCB2727   RY-B-E3   Rat cell line derived from endometrial stromal sarcoma.  


RCB2728   LY-H12   Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.  


RCB2729   LY-PPB6   Rat cell line derived from malignant peripheral nerve sheath tumor.  


RCB2740   5A5-WASP   Hybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein). TKG0631 (Deposited from Tohoku Univ.).  


RCB2745   A20   Mouse cell line derived from lymphoma. Balb/c strain.TKG0571 (Deposited from Tohoku Univ.).  


RCB2758   LAG   Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).  


RCB2766   Morris 5123D-TC   Rat (Buffalo) cell line derived from hepatoma. TKG0365(Deposited from Tohoku Univ.).  


RCB2767   NIH/3T3   Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).  


RCB2776   P388   Mouse cell line derived from lymphoid tumor. DBA/2 strain.TKG0326 (Deposited from Tohoku Univ.).  


RCB2782   RBL 2H3   Rat cell line derived from basophilic leukemia cells.TKG0321 (Deposited from Tohoku Univ.).  


RCB2783   RGC-6   Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).  


RCB2784   RL♂1(Gloria)   Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).  


RCB2799   YAC-1   Mouse cell line derived from lymphoma. A/Sn strain.TKG0387 (Deposited from Tohoku Univ.).  


RCB2800   PC12-F7   A subline of PC-12 lacking synaptotagmin-1.  


RCB2801   PC12-G11   A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.  


RCB2806   MSK-C5.8G   Rat cell line derived from osteosarcoma. F344 strain.  


RCB2808   Odf2-deficient F9 cells   A subline of mouse ES cell line, F9 (129), lacking Odf2.  


RCB2809   CH12F3-2A   Mouse cell line derived from B cell lymphoma.  


RCB2811   7F9 (hybridoma)   Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.  


RCB2812   HeLa/Fucci   A subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4. Important notice regarding nomenclature of Fucci.  


RCB2813   NMuMG/Fucci   A subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.  


RCB2814   COS/Fucci   Subline of COS cell line expressing Fucci, a marker of cell cycle.??Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Important notice regarding nomenclature of Fucci.  


RCB2815   P20.1   Hybridoma producing monoclonal antibody against a peptide, GYPGQV.  


RCB2816   A110L   Human cell line derived from lung adenocarcinoma cells.  


RCB2817   A529L   Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.  


RCB2818   B1203L   Human cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.  


RCB2819   C831L   Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.  


RCB2830   OMC-2   Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.  


RCB2831   DEOC-1   Human cell line derived from malignant melanoma. Cell growth is slow.  


RCB2832   OMC-9   Human cell line derived from endometrial stromal sarcoma.  


RCB2833   L23immo   Human immortalized cell line derived from MRC5 cells.  


RCB2834   L12.9-2(1)   Human immortalized cell line derived from MRC5 cells.  


RCB2843   43L   Hybrid cell line of C3H mouse mammary tumor cell, FM3A#2, and 8-Ag resistant L cell. TKG0381 (Deposited from Tohoku Univ.).  


RCB2844   L1210 TGR4   Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).  


RCB2845   L1210-5FU-R-TC   Mouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).  


RCB2846   LAG-MUC1   A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).  


RCB2848   OTT6050(B)   Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330 (Deposited from Tohoku Univ.).  


RCB2852   TSA8   Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370 (Deposited from Tohoku Univ.).  


RCB2853   WEHI-3B   Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).  


RCB2854   C6   Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).  


RCB2859   K-251   Rat cell line derived from hepatoma cells in ascites.TKG0130 (Deposited from Tohoku Univ.).  


RCB2860   MRMT-1   Rat cell line derived from mammary carcinoma. TKG0132(Deposited from Tohoku Univ.).  


RCB2862   SLC   Rat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).  


RCB2863   N14.5   Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  


RCB2864   OLP6   Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  


RCB2867   HeLa/Fucci2   A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.  


RCB2868   NMuMG/Fucci2   A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5.Important notice regarding nomenclature of Fucci.  


RCB2869   CHO-K1   A subline of CHO cells. Require proline. TKG0328(Deposited from Tohoku Univ.).  


RCB2896   JLS-V9 6TG   Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350 (Deposited from Tohoku Univ.).  


RCB2899   S180-Kumamoto-TC   Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).  


RCB2900   S180-Meiji-TC   Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).  


RCB2901   S180-NCC-TC   Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).  


RCB2904   WEHI164R   Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).  


RCB2905   WEHI164S   Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).  


RCB2908   AH272-TC   Rat cell line derived from hepatoma cells in ascites.TKG0535 (Deposited from Tohoku Univ.).  


RCB2909   Walker256-TC   Rat cell line derived from mammary carcinoma. TKG0565(Deposited from Tohoku Univ.).  


RCB2910   LY-6-TC   Rat cell line derived from sarcoma cells in ascites. TKG0648(Deposited from Tohoku Univ.).  


RCB2911   MEDEP-BRC5   Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.  


RCB2924   OP9/G   Subline of OP9 cell line, expressing EGFP. Cell growth is slow.??See RCB2117 TSt-4/G.  


RCB2925   OP9/G-DLL1   Subline of OP9 cell line, expressing DLL1 and EGFP. Cell growth is slow. See RCB2118 TSt-4/G-DLL1.  


RCB2926   OP9/N   Subline of OP9 cell line, expressing human NGF receptor. Cell growth is slow. See RCB2119 TSt-4/N.  


RCB2927   OP9/N-DLL1   Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.  


RCB2930   R4A9   Hybridoma cell line expressing a monoclonal antibidy against H-1 cells, a mouse bone marrow cell line. The target molecule in unknown  


RCB2931   6E2   Hybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.  


RCB2932   MEDEP-BRC4-2   Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.  


RCB2942   OLHNI-2   Medaka cell line derived from HNI strain.  


RCB2943   OLHdrR-e3   Medaka cell line derived from HdrR strain.  


RCB2944   OLCAB-e31   Medaka cell line derived from HB32 strain.  


RCB2945   DIT29   Medaka cell line derived from hepatoma cells.  


RCB2946   OLCAB-e3   Medaka cell line derived from HB32 strain.  


RCB2979   HCT116   Human cell line derived from colon cancer.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2980   HCT116-XRCC4(+/-)   Subline of HCT116 cell line lacking XRCC4 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2981   HCT116-XRCC4(-/-)   Subline of HCT116 cell line lacking XRCC4 gene in both alleles.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2982   HCT116-RAD18(+/-)   Subline of HCT116 cell line lacking RAD18 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2983   HCT116-RAD18(-/-)   Subline of HCT116 cell line lacking RAD18 gene in both alleles.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2984   HCT116-ARTEMIS(+/-)   Subline of HCT116 cell line lacking ARTEMIS gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2985   HCT116-ARTEMIS(-/-)   Subline of HCT116 cell line lacking ARTEMIS gene in both alleles.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2986   HCT116-MDC1(+/-)   Subline of HCT116 cell line lacking MDC1 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2987   HCT116-MDC1(-/-)   Subline of HCT116 cell line lacking MDC1 gene in both alleles.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2988   HCT116-REV1(+/-)   Subline of HCT116 cell line lacking REV1 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2989   HCT116-REV1(-/-)   Subline of HCT116 cell line lacking REV1 gene in both alleles.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2990   HCT116-REV3L(+/-)   Subline of HCT116 cell line lacking REV3L gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2991   HCT116-KU70(+/-)   Subline of HCT116 cell line lacking Ku70 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2992   HCT116-DNAPKcs(+/-)   Subline of HCT116 cell line lacking DNAPKcs gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2993   HCT116-POLM(+/-)   Subline of HCT116 cell line lacking DNA polymerase m gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2994   HCT116-LIG3(+/-)   Subline of HCT116 cell line lacking Ligase 3 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2995   HCT116-LIG4(+/-)   Subline of HCT116 cell line lacking Ligase 4 gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2996   HCT116-53BP1(+/-)   Subline of HCT116 cell line lacking 53BPI gene in one allele.??Loss of the DNA mismatch repair gene (hMLH1).  


RCB2997   H414   Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).  


RCB2998   H414-RAD18(+/-)   Subline of H414 cell line lacking RAD18 gene in one allele.  


RCB2999   H414-RAD18(-/-)   Subline of H414 cell line lacking RAD18 gene in both alleles.  


RCB3000   H414-MDC1(+/-)   Subline of H414 cell line lacking MDC1 gene in one allele.  


RCB3001   H414-MDC1(-/-)   Subline of H414 cell line lacking MDC1 gene in both alleles.  


RCB3002   H414-LIG4(+/-)   Subline of H414 cell line lacking Ligase 4 gene in one allele.  


RCB3007   MOPC-70A   Mouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).  


RCB3008   NC37   HGPRT(-), resistant to ouabain, partner cells for human B hybridoma. Ig nonproducer, human B lymphoblastoid cell line. This line and Raji(TKG0371)are derived from the same individual. TKG0232 (Deposited from Tohoku Univ.).  


RCB3010   RPMI8226   Human cell line derived from myeloma. IgG producer.TKG0243 (Deposited from Tohoku Univ.).  


RCB3052   Jurkat   Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209(Deposited from Tohoku Univ.).  


RCB3515   JLS-V9 BudR   Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356 (Deposited from Tohoku Univ.).  


RCB3530   B901L   Human cell line derived from lung adenocarcinoma cells.  


RCB3531   A904L   Human cell line derived from lung large cell carcinoma cells.  


RCB3532   A129L   Human cell line derived from lung adenocarcinoma cells.  


RCB3576   Aska-SS   Human cell line derived from synovial sarcoma.  


RCB3577   Yamato-SS   Human cell line derived from synovial sarcoma.  


RCB3586   hPSC-1   Human cell line derived from choronic pancreatitis. Pancreatic stellate cells.  


RCB3588   hPSC-5   Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  


RCB3589   hPSC-14   Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  


RCB3600   SDR-P-1D5   Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.  


RCB3601   SDRL-1   Rat cell line derived from liver lacking growth hormone.  


RCB3602   SDRL-2   Rat cell line derived from liver lacking growth hormone.  


RCB3673   Raji   Human cell line derived from Burkitt lymphoma. EBNA (EBV??nuclear antigen) positive. TKG0371 (Deposited from Tohoku Univ.).  


RCB3675   SCC-TC   Rectal carcinoma. Culture cell line of SCC (TKG 0340) .TKG0646 (Deposited from Tohoku Univ.).  


RCB3676   5637   Human cell line derived from bladder carcinoma. TKG0605(Deposited from Tohoku Univ.).  


RCB3677   A549   Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184(Deposited from Tohoku Univ.).  


RCB3678   BeWo   Human cell line derived from choriocarcinoma. TKG0567(Deposited from Tohoku Univ.).  


RCB3680   HeLa   Human cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).  


RCB3681   HeLa.P3(S)   Subline of HeLa cell line. Serum-free culture is possible.TKG0465 (Deposited from Tohoku Univ.).  


RCB3682   HeLa S3   Human cell line derived from cervical cancer. TKG0444(Deposited from Tohoku Univ.).  


RCB3683   HL-60   Human cell line derived from promyelocytic leukemia cells.TKG0345 (Deposited from Tohoku Univ.).  


RCB3685   HMV-II   Human cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).  


RCB3686   THP-1   Human cell line derived from monocytic leukemia.TKG0267 (Deposited from Tohoku Univ.).  


RCB3687   MKN-7   Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma).TKG0228 (Deposited from Tohoku Univ.).  


RCB3688   Saos-2   Human cell line derived from osteogenic sarcoma cells.TKG0469 (Deposited from Tohoku Univ.).  


RCB3706   Atg7 +/+ MEFs   Mouse embryonic fibroblasts derived from wild type mouse (C57BL/6).  


RCB3707   Atg7 -/- MEFs   Mouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).  


RCB3708   Atg3 +/+ MEFs   Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.  


RCB3709   Atg3 -/- MEFs   Mouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.  


RCB4451   UPS-1   Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).  


RCB4452   FL-YB   Mouse follicular dendritic cell line  


RCB4455   PC-9   Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)  


RCB4472   IN-IC   Rat cell line derived from kidney.  


RCB4474   Ba/F3-CL1   Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3).??Information  


RCB4476   Ba/F3   Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information  


RCB4477   ACK2   Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  


RCB4478   ACK4   Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  


RCB4479   ACK30   Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  


RCB4480   ACK45   Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.  


RCB4481   A7R34   Hybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.  


RCB4482   APA5   Hybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.  


RCB4483   APB5   Hybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.  


RCB4484   Avas12   Hybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.  


RCB4485   A2F10   Hybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.  


RCB4486   AFS98   Hybridoma cell line producing anti-mouse c-fms (CD115) antibody.  


RCB4487   ACD1   Hybridoma cell line producing anti-mouse CDK4 antibody.  


RCB4488   AFL4   Hybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration  


RCB4489   MB86   Hybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.  


RCB4498   NP 2   Human cell line derived from anaplastic glioma.  


RCB4499   Onda 10   Human cell line derived from anaplastic glioma.  


RCB4500   Onda 11   Human cell line derived from glioblastoma.  


RCB4504   NP 3   Human cell line derived from anaplastic glioma.  


RCB4505   NP 5   Human cell line derived from anaplastic glioma.  


RCB4516   STIM2^(-/-)DT40   A subline of avian cell line, DT40, lacking STIM2 gene.  


RCB4517   STIM1^(-/-)STIM2^(-/-)DT40   A subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.  


RCB4518   Orai1^(-/-)DT40   A subline of avian cell line, DT40, lacking Orai1 gene.  


RCB4519   Orai2^(-/-)DT40   A subline of avian cell line, DT40, lacking Orai2 gene.  


RCB4548   PT-r   Rat cell line derived from parathyroid gland.  


RCB4561   MOLT-17   Human cell line derived from T cell leukemia (T-ALL). ACC 36 (Deposited from DMSZ.).  


RCB4563   TSt-4/N-DLL4   Original murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.  


RCB4592   r/mHM-SFME-1   Comment.  


RCB4593   CALM WT MEF   CALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.????????  


RCB4594   CALM KO MEF   CALM deficient MEF cells. Tranformed with SV40 large T antigen gene.  


RCB4623   Ba/ER   Ba/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.  


RCB4627   KUP5   An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 ***** mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution).  


RCB4635   #16-15   Hybridoma cell line producing anti-human BEND3 antibody (rat IgM).  


RCB4662   HCT116 CMV-OsTIR1   This is an HCT116 cell line in which CMV-OsTIR1 (pMK232, PURO) was introduced at the both alleles of the AAVS1 locus by using CRISPR/Cas.This parental cell line consitutively express OsTIR1 and can be used for generation of AID mutants.  


RCB4676   HeLa/Fucci(CA)2   A subline of the HeLa cell line expressing FucciCA, a cell cycle marker. Important notice regarding nomenclature of Fucci.  


RCB4680   MS-5   Mouse stromal cell line which supports hematopoietic cells.  


RCB4681   MS-K   Murine cell line derived from sarcoma.  


RCB4693   ChR2-C2C12   A subline of the murine C2C12 cell line??(RCB0987) which stably expresses??channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.  

姓名:
電話:
您的需求:
 
人人妻人人爽人人叫-亚洲中文字幕无码va-两个人看的视频在线观看-久久综合九色综合久99